Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3045684	s-afmakro	u/l (u/l)	2054	2528	0.00%
3045684	s-afmakro	— (—)	369	397	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

ILD medications: immunosuppressive drugs

615

1132

5.11

282.97

1.3

1.2

24.10

20.50

u/l

0.82

540

974

Diseases of liver

461

725

6.51

278.97

1.3

1.2

32.45

19.57

u/l

4.02

410

607

Dialysis, with operation codes

263

203

13.57

277.05

1.4

1.2

41.23

20.06

u/l

3.96

241

165

Chronic kidney disease

384

546

7.05

249.00

1.3

1.2

31.28

23.43

u/l

1.69

346

451

Renal failure

499

805

5.58

247.25

1.3

1.2

36.53

24.44

u/l

3.51

446

664

Nephropathy related operations

248

210

12.36

246.76

1.4

1.2

41.00

22.59

u/l

2.97

227

176

All chronic kidney diseases

513

888

4.79

209.24

1.3

1.2

31.62

21.19

u/l

3.44

457

757

Care involving dialysis

181

120

15.91

208.02

1.4

1.2

26.63

19.38

u/l

1.04

166

Autoimmune diseases excluding thyroid diseases

763

1136

3.69

193.96

1.3

1.2

26.08

23.94

u/l

0.42

675

964

Autoimmune diseases excluding thyroid diseases, strict definition

735

1085

3.74

190.19

1.3

1.2

25.80

23.39

u/l

0.49

653

919

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

743

1499

3.45

186.47

1.3

1.2

28.77

22.66

u/l

2.06

658

1282

Transplanted organ and tissue status

180

143

13.11

186.19

1.4

1.1

30.17

22.48

u/l

0.69

166

122

Renal tubulo-interstitial diseases

682

1433

3.58

185.14

1.3

1.2

34.33

19.97

u/l

7.19

605

1213

Anaemias

217

108

13.30

176.32

1.3

1.2

30.68

12.23

u/l

5.13

196

L04AD Calcineurin inhibitors

192

191

10.45

171.24

1.4

1.1

27.46

22.31

u/l

0.49

175

163

ILD medications

768

1253

3.35

169.70

1.3

1.2

26.14

21.73

u/l

1.14

664

1087

All kidney diseases

705

1479

3.28

163.98

1.3

1.2

32.52

20.13

u/l

5.81

619

1270

First line medication for Crohn's disease

735

1189

3.36

163.51

1.3

1.2

27.36

21.08

u/l

1.86

635

1023

Bacterial infection, other or unspecified

490

1052

3.98

160.89

1.3

1.2

42.61

19.44

u/l

9.34

456

873

ILD medications: prednisolone, methylprednisolone, prednisone

727

1246

3.29

158.25

1.4

1.2

26.69

21.84

u/l

1.23

626

1080

Other diseases of liver

246

365

6.92

157.76

1.3

1.2

30.88

18.04

u/l

2.06

219

309

Bacterial infection, other or unspecified

462

1001

4.05

156.51

1.3

1.2

44.04

19.49

u/l

9.46

430

832

Other bacterial diseases

686

1443

3.22

154.08

1.3

1.2

37.07

18.39

u/l

9.45

618

1216

Autoimmune diseases related-to ILD

627

1668

3.24

152.77

1.3

1.2

26.47

23.72

u/l

0.49

549

1434

Fibrosis and cirrhosis of liver

153

133

12.06

149.79

1.4

1.1

33.22

14.43

u/l

3.15

139

115

Preparatory care for dialysis

116

20.08

148.59

1.4

1.2

23.83

20.41

u/l

0.33

105

L04AA Selective immunosuppressants

268

475

5.76

143.81

1.3

1.2

28.45

19.51

u/l

1.36

245

399

ILD medications: azathioprine

182

212

8.78

143.75

1.3

1.1

27.11

18.72

u/l

0.81

159

179

Inflammatory bowel disease treatment related agents

749

1414

2.98

139.95

1.3

1.2

25.04

23.21

u/l

0.34

644

1228

IBD patients in KELA-register

246

420

5.96

137.16

1.4

1.2

20.64

19.38

u/l

0.11

206

360

Other bacterial diseases

686

1447

3.03

137.14

1.3

1.2

36.47

17.41

u/l

9.76

619

1222

Azathioprine

182

233

7.99

133.05

1.3

1.2

27.11

18.15

u/l

0.91

159

197

Heart failure, not strict

556

1139

3.35

132.88

1.3

1.2

32.10

20.82

u/l

4.35

495

950

Dental caries

257

447

5.61

132.81

1.3

1.2

34.19

23.28

u/l

1.73

233

377

Inflammatory bowel disease, strict (require KELA)

246

435

5.76

132.23

1.4

1.2

20.64

19.73

u/l

0.08

206

376

Tramadol

560

1043

3.32

128.35

1.3

1.2

32.51

20.26

u/l

3.88

481

899

Second line medication for Crohn's disease

457

1336

3.45

128.27

1.3

1.2

22.61

22.75

u/l

0.02

397

1143

Bacterial Sepsis

391

858

3.94

127.06

1.4

1.2

38.52

20.67

u/l

6.36

351

727

Primary biliary cholangitis (PBC)

31.69

125.70

1.4

1.0

31.32

15.29

u/l

1.01

Examination and observation for other reasons

453

685

3.86

125.14

1.2

21.25

24.21

u/l

0.64

410

587

Implicit bacterial Sepsis

349

751

4.17

123.73

1.3

1.2

40.76

21.52

u/l

5.99

313

626

Glomerular disorders in diseases classified elsewhere

163

201

8.35

123.17

1.4

1.2

32.44

25.05

u/l

0.77

156

167

5-aminosalicylic acid

217

365

6.04

122.87

1.4

1.2

22.13

17.80

u/l

0.44

182

313

Kidney transplant status

113

14.35

122.70

1.4

1.2

22.83

16.67

u/l

0.87

102

Mucosal proctocolitis

164

206

8.16

121.91

1.4

1.1

23.32

20.58

u/l

0.17

137

171

Extracorporeal dialysis

117

12.91

119.60

1.6

1.2

27.55

18.08

u/l

1.67

108

L04AX Other immunosuppressants

438

1312

3.37

118.35

1.2

22.65

22.99

u/l

0.04

381

1121

Septicaemia

335

778

4.07

117.18

1.3

1.2

37.03

19.53

u/l

6.73

299

642

Inflammatory bowel disease

289

659

4.45

115.51

1.4

1.2

21.72

20.74

u/l

0.10

244

560

Polyarthropathies

496

987

3.31

115.34

1.2

1.3

25.86

26.98

u/l

0.16

437

854

Caries of dentine

222

392

5.60

114.90

1.3

1.2

34.14

22.67

u/l

1.68

201

329

Noninfective enteritis and colitis

370

1022

3.65

113.15

1.4

1.2

23.71

21.73

u/l

0.26

315

864

Glomerular diseases

202

345

5.98

112.78

1.4

1.2

30.95

21.95

u/l

1.53

191

287

Implicit bacterial Sepsis

362

833

3.79

112.16

1.3

1.2

41.16

20.89

u/l

6.46

326

703

Budesonide

168

246

6.98

109.09

1.5

1.1

21.51

17.57

u/l

0.50

144

210

Autoimmune diseases

641

1146

2.86

108.28

1.3

1.2

25.16

23.79

u/l

0.21

559

973

Explicit Sepsis

339

842

3.80

107.72

1.3

1.2

36.85

20.42

u/l

5.99

303

710

Other septicaemia

297

699

4.13

106.88

1.3

1.2

37.06

19.90

u/l

5.95

266

567

Persons encountering health services for specific procedures and health care

666

1492

2.69

106.52

1.3

1.2

28.59

21.46

u/l

2.14

596

1271

Ulcer of lower limb, not elsewhere classified

170

260

6.69

106.00

1.3

1.2

36.63

21.69

u/l

2.98

155

216

Acute renal failure

204

374

5.55

105.57

1.3

1.2

49.35

22.40

u/l

4.62

185

300

Unspecified kidney failure

131

156

8.62

101.83

1.2

1.3

31.94

23.34

u/l

0.85

112

131

Implicit Sepsis

505

1322

2.90

98.95

1.3

1.2

37.09

20.76

u/l

6.15

444

1118

Fever of other and unknown origin

376

1011

3.34

97.33

1.4

1.2

37.59

19.36

u/l

6.89

343

855

Used for control exclusion in common control thyroid runs

577

1030

2.84

96.47

1.3

1.2

24.81

23.84

u/l

0.13

503

872

Disorders resulting from impaired renal tubular function

16.31

96.39

1.4

1.2

20.85

17.68

u/l

0.31

GASTRO-related operations

420

611

3.46

95.21

1.2

1.1

22.94

14.79

u/l

2.21

372

495

Any gastric operation

420

611

3.46

95.21

1.2

1.1

22.94

14.79

u/l

2.21

372

495

Ulcerative colitis

223

489

4.63

93.76

1.4

1.2

22.55

20.17

u/l

0.21

185

414

Abnormal findings on examination of blood, without diagnosis

340

925

3.41

91.62

1.3

1.2

30.57

27.24

u/l

0.45

302

778

Implicit Sepsis

520

1399

2.73

90.75

1.3

1.2

36.33

20.02

u/l

6.41

454

1187

Any reimbursement code in KELA

276

297

4.68

90.32

1.2

1.1

22.88

16.84

u/l

0.78

241

253

Reimbursement for rheumatic diseases

414

1405

2.96

90.03

1.2

22.27

22.63

u/l

0.05

369

1188

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

178

336

5.39

89.30

1.4

1.2

20.98

20.37

u/l

0.04

148

287

Cholangitis (primary sclerosing, PSC)

10.68

87.24

1.3

1.2

40.76

15.70

u/l

1.92

Oral corticosteroids

599

1397

2.56

86.72

1.3

1.2

29.54

23.38

u/l

1.36

515

1212

Ulcerative colitis (strict definition, require KELA)

169

313

5.49

86.61

1.4

1.2

21.33

20.65

u/l

0.04

140

266

Osteopathies and chondropathies

403

1279

2.96

86.34

1.3

1.2

27.77

22.43

u/l

1.25

351

1082

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

165

300

5.60

86.28

1.4

1.2

21.74

21.16

u/l

0.03

137

254

Pneumonias (Asthma/COPD co-morbidities)

599

1617

2.50

85.80

1.3

1.2

35.78

19.24

u/l

7.26

534

1383

Dialysis

14.69

84.85

1.4

1.2

19.45

18.47

u/l

0.08

Metabolic disorders

578

1383

2.56

84.84

1.3

1.2

27.28

23.72

u/l

0.76

505

1185

Crohn disease

139

218

6.50

84.61

1.4

1.2

23.04

20.19

u/l

0.24

120

182

All pneumoniae

600

1624

2.48

84.58

1.3

1.2

35.66

19.24

u/l

7.19

535

1390

Aplastic and other anaemias

342

1000

3.22

84.50

1.3

1.2

34.52

24.61

u/l

2.62

302

840

Influenza and pneumonia

615

1605

2.45

83.17

1.3

1.2

35.22

18.96

u/l

7.24

548

1374

Disorders of parathyroid gland

208

474

4.41

81.87

1.3

1.2

15.86

22.77

u/l

1.88

180

391

Heart failure,strict

342

738

3.30

81.31

1.2

1.3

34.89

21.54

u/l

3.73

301

606

545

1286

2.58

80.82

1.3

1.2

35.60

19.00

u/l

6.50

484

1098

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

545

1286

2.58

80.82

1.3

1.2

35.60

19.00

u/l

6.50

484

1098

Other anaemias

319

944

3.24

80.26

1.3

1.2

34.28

24.86

u/l

2.25

281

795

Insulin, fast-acting

264

734

3.63

80.25

1.3

1.2

36.19

20.85

u/l

3.87

237

617

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

153

280

5.58

79.54

1.3

1.2

39.46

20.44

u/l

3.73

140

231

Secondary hypertension

107

9.17

78.82

1.3

1.1

18.93

18.91

u/l

0.00

Other and unspecified anaemias

314

934

3.24

78.73

1.3

1.2

34.35

24.98

u/l

2.18

276

788

Insulin, intermediate and long-acting

360

1192

2.96

77.92

1.3

1.2

34.10

23.59

u/l

3.00

324

1009

Condition for Implicit Sepsis (Organ dysfunction codes)

524

1433

2.53

77.83

1.3

1.2

33.76

19.71

u/l

5.66

461

1225

Other Crohn's disease

101

9.47

77.73

1.3

1.1

20.75

14.87

u/l

0.72

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

574

1628

2.42

76.98

1.3

1.2

35.67

19.53

u/l

6.65

512

1392

Condition for Implicit Sepsis (Organ dysfunction codes)

510

1425

2.54

76.56

1.3

1.2

35.30

19.75

u/l

5.93

446

1213

Nonalcoholic fatty liver disease

126

201

6.44

75.61

1.2

1.1

27.84

18.05

u/l

0.85

106

170

Diabetic nephropathy, excluding more controls

160

249

5.40

74.75

1.4

1.2

32.93

27.87

u/l

0.46

149

215

Hyperparathyroidism

186

419

4.46

74.46

1.3

1.2

14.76

22.04

u/l

2.03

161

346

Malaise and fatigue

336

885

3.08

74.42

1.2

28.60

20.24

u/l

2.78

287

748

Insulin, fast-acting or short human

266

782

3.43

74.28

1.3

1.2

35.92

21.74

u/l

3.46

239

656

Pneumonia, organism unspecified

530

1523

2.45

73.87

1.3

1.2

37.07

19.39

u/l

6.88

469

1297

Insulin, combination of fast acting with intermediate-acting or long-acting

391

1309

2.75

72.99

1.3

1.2

35.23

24.37

u/l

3.17

352

1114

Nutritional anaemias

346

1164

2.89

71.67

1.3

1.2

28.74

24.65

u/l

0.77

307

988

Insulin medication

391

1213

2.73

70.69

1.3

1.2

35.23

23.33

u/l

3.72

352

1033

Other disorders of kidney and ureter

136

250

5.55

70.42

1.3

1.2

19.27

21.65

u/l

0.30

122

207

Type 1 diabetes

191

464

4.16

70.29

1.3

34.08

20.74

u/l

2.38

176

390

Diabetic nephropathy

162

345

4.73

69.48

1.4

1.2

33.99

29.64

u/l

0.42

151

296

Implicit viral Sepsis

212

562

3.81

69.25

1.3

1.2

41.50

21.32

u/l

3.88

191

462

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

552

1535

2.35

69.09

1.3

1.2

26.42

23.08

u/l

0.72

484

1315

Certain infectious and parasitic diseases

517

1039

2.50

68.28

1.3

1.2

26.00

17.42

u/l

2.60

442

881

Abnormal serum enzyme levels

210

554

3.73

66.15

1.3

33.71

27.22

u/l

0.76

183

461

Disorders of gallbladder, biliary tract and pancreas

565

1568

2.28

65.58

1.3

1.2

32.56

22.68

u/l

2.77

492

1341

Ulcerative colitis, NAS

130

245

5.39

65.45

1.2

1.1

19.26

20.24

u/l

0.10

108

203

Disorders of other endocrine glands

306

1039

2.92

65.05

1.3

1.2

19.49

22.74

u/l

0.81

266

880

Iron deficiency anaemia

297

994

2.97

65.03

1.3

1.2

29.94

23.57

u/l

1.28

264

841

General symptoms and signs

560

1199

2.35

64.92

1.3

1.2

26.91

18.66

u/l

2.95

485

1028

Other and unspecified iron deficiency

242

731

3.34

64.82

1.3

1.2

28.22

23.41

u/l

0.85

216

607

Heart failure, strict

364

937

2.76

64.22

1.2

34.96

25.25

u/l

2.33

318

788

Crohn's disease NAS

8.68

64.15

1.4

1.1

26.70

14.89

u/l

1.02

Type 1 diabetes, wide definition, subgroup 1

156

355

4.44

62.63

1.3

1.2

32.83

17.22

u/l

3.29

145

301

Erysipelas

403

1214

2.55

62.29

1.3

1.2

33.99

18.77

u/l

4.83

345

1011

Diseases of oesophagus, stomach and duodenum

578

1564

2.22

62.04

1.3

1.2

23.01

24.74

u/l

0.37

497

1355

Erysipelas

328

1061

2.75

61.11

1.3

1.2

34.19

20.07

u/l

3.95

285

882

Exposure to unspecified factor

551

1810

2.20

60.65

1.3

1.2

24.53

24.27

u/l

0.04

465

1580

Ulcerative colitis (strict definition, all Crohn cases excluded)

126

250

5.12

59.89

1.3

1.2

19.59

21.74

u/l

0.12

104

209

Acute tubulo-interstitial nephritis

358

1192

2.61

59.66

1.3

1.2

32.76

19.95

u/l

3.72

313

1004

Heart failure and antihypertensive medication

184

290

4.19

59.53

1.2

37.16

18.81

u/l

4.38

164

239

All-cause Heart Failure

351

928

2.69

59.05

1.2

34.78

24.63

u/l

2.43

305

780

Opioids

498

1111

2.34

57.84

1.2

26.84

19.74

u/l

1.73

422

964

Gout, FINNGEN

189

529

3.60

56.86

1.3

36.82

28.49

u/l

0.92

166

439

Infections, IBD-co-morbidities

114

136

6.05

56.74

1.3

32.84

21.90

u/l

1.06

101

118

Hypertensive diseases (excluding secondary)

289

561

3.01

56.11

1.3

1.2

19.65

18.93

u/l

0.10

253

481

Type 1 diabetes, wide definition

157

391

4.05

56.00

1.3

1.2

32.73

20.48

u/l

1.92

146

332

Implicit viral Sepsis

149

359

4.20

55.70

1.3

1.2

41.95

20.83

u/l

3.13

137

298

Viral Sepsis

149

359

4.20

55.70

1.3

1.2

41.95

20.83

u/l

3.13

137

298

Other diseases of intestines

537

1413

2.17

53.98

1.3

1.2

27.34

21.66

u/l

1.24

458

1229

Persons encountering health services for other counselling and medical advice, not elsewhere classified

592

1541

2.10

53.93

1.3

1.2

23.24

24.93

u/l

0.35

527

1316

Complications of surgical and medical care, not elsewhere classified

539

1746

2.12

53.78

1.3

1.2

30.20

23.38

u/l

1.77

467

1509

Other heart diseases

261

564

3.04

53.52

1.3

1.2

25.38

18.83

u/l

1.60

238

482

Gout

189

476

3.53

53.39

1.3

36.82

30.68

u/l

0.58

166

398

Oedema, not elsewhere classified

214

666

3.20

53.37

1.3

1.2

32.11

19.92

u/l

1.85

182

558

Insulin, fast-acting (human)

112

222

5.11

53.30

1.4

1.1

34.92

22.22

u/l

1.18

102

183

Intestinal infectious diseases

509

1809

2.14

53.30

1.3

1.2

28.47

23.64

u/l

1.24

448

1556

Diseases of arteries, arterioles and capillaries

393

1219

2.40

52.97

1.3

1.2

32.59

24.61

u/l

1.72

344

1036

Gastrointestinal diseases

266

425

3.15

52.75

1.2

24.44

15.54

u/l

1.53

233

361

Other inflammatory liver diseases

110

7.27

52.61

1.2

1.1

30.42

14.77

u/l

1.08

Other disorders of skin and subcutaneous tissue

410

1596

2.30

52.31

1.3

1.2

27.70

24.20

u/l

0.76

353

1370

Codeine

460

1094

2.29

52.01

1.2

22.50

19.91

u/l

0.58

388

948

Sub-endpoint used in defining T1D endpoints

192

567

3.36

51.88

1.3

1.2

33.12

24.11

u/l

1.35

177

476

Diseases of arteries, arterioles and capillaries (FINNGEN)

169

299

3.95

51.85

1.3

1.2

25.97

21.42

u/l

0.55

145

247

Hypertension, essential

402

946

2.42

51.51

1.3

1.2

22.42

22.65

u/l

0.03

352

812

Diarrhoea and gastroenteritis of presumed infectious origin

384

1495

2.32

50.67

1.3

1.2

28.42

22.51

u/l

1.37

336

1282

Malignant neoplasm of breast, HER2-negative

297

716

2.74

50.60

1.2

17.50

20.46

u/l

0.41

262

614

Intestinal infectious diseases

597

1692

2.02

50.29

1.3

1.2

27.52

23.27

u/l

1.01

522

1460

Hypertension

405

965

2.38

50.19

1.3

1.2

22.73

22.41

u/l

0.04

355

831

Hypertensive diseases

404

965

2.37

49.83

1.3

1.2

22.77

22.41

u/l

0.05

354

831

Pain in limb

433

1291

2.25

49.76

1.2

28.50

24.28

u/l

0.77

373

1117

Malignant neoplasm of breast

296

721

2.70

49.15

1.2

17.54

20.50

u/l

0.41

261

619

Heart failure and bmi 25plus

216

458

3.21

48.90

1.2

37.29

24.97

u/l

2.07

185

386

Other disorders of fluid, electrolyte and acid-base balance

208

645

3.10

48.82

1.3

30.08

22.88

u/l

1.25

181

535

Other arthritis (FG)

203

658

3.11

48.59

1.2

1.3

25.05

21.98

u/l

0.39

184

558

Cardiovascular diseases (excluding rheumatic etc)

305

657

2.68

48.34

1.2

21.99

18.06

u/l

0.70

273

566

Finngen Rheumatological endpoints

482

1273

2.16

48.13

1.2

1.3

22.24

24.66

u/l

0.49

418

1108

Malignant neoplasm of breast, HER2-negative, including Hilmo

297

728

2.66

47.96

1.2

16.98

20.39

u/l

0.51

262

624

Adjustment and management of implanted device

131

321

4.13

47.96

1.2

36.98

23.51

u/l

2.06

118

270

Malignant neoplasm of breast, including Hilmo

297

728

2.66

47.95

1.2

16.98

20.39

u/l

0.51

262

624

Crohn's disease of large intestine

8.21

47.91

1.3

1.1

22.75

14.13

u/l

0.88

Persons encountering health services for specific procedures, not carried out

116

6.67

47.59

1.3

1.1

26.79

17.07

u/l

1.13

Crohn's disease of small intestine

107

6.87

46.28

1.6

1.1

19.43

14.74

u/l

0.46

Crohn disease (strict definition, require KELA, min 2 HDR)

101

7.09

46.25

1.3

1.2

18.88

16.92

u/l

0.15

Chronic hepatitis, not elsewhere classified

10.37

46.24

1.3

1.1

20.02

14.69

u/l

0.94

Crohn disease (strict definition, require KELA)

103

6.95

45.42

1.3

1.2

18.88

16.80

u/l

0.17

Malignant neoplasm of breast, HER-positive

234

644

2.86

45.37

1.2

15.91

19.71

u/l

0.59

209

548

Unspecified privation

181

5.22

45.30

1.2

36.68

17.63

u/l

1.75

152

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

116

6.52

45.23

1.3

1.2

18.25

15.92

u/l

0.20

101

Malignant neoplasm

433

1174

2.19

45.18

1.3

1.2

26.36

21.69

u/l

0.84

383

1006

Pain in joint

305

768

2.54

45.08

1.2

20.66

23.82

u/l

0.50

262

661

Malignant neoplasm of breast, ER-positive, including Hilmo

236

647

2.84

45.05

1.2

15.82

19.64

u/l

0.61

211

551

Disorders of lipoprotein metabolism and other lipidaemias

438

1259

2.16

44.86

1.2

25.51

24.11

u/l

0.21

383

1072

Care involving use of rehabilitation procedures

340

1361

2.31

44.44

1.2

26.45

21.74

u/l

0.67

297

1149

Gout, idiopatic and unspecified

160

478

3.38

43.90

1.3

36.59

27.48

u/l

0.91

143

393

Osteoporosis

199

629

2.99

43.66

1.3

1.2

27.12

23.58

u/l

0.40

169

535

Amputation

176

5.20

43.59

1.4

1.3

45.89

23.26

u/l

2.22

148

Complications of procedures, not elsewhere classified

430

1703

2.10

43.54

1.3

1.2

30.04

23.53

u/l

1.32

371

1468

Endocrine, nutritional and metabolic diseases

363

779

2.37

43.25

1.2

21.40

20.04

u/l

0.18

321

658

Peripheral artery disease

256

776

2.64

43.23

1.3

33.45

25.73

u/l

1.53

229

649

Bleeding

445

1525

2.08

42.89

1.3

1.2

30.64

23.74

u/l

1.67

391

1294

Gout, strict definition

125

323

3.92

42.62

1.2

1.3

30.07

25.03

u/l

0.51

112

263

Other specified/unspecified arthritis

180

588

3.09

42.60

1.2

1.3

21.35

24.18

u/l

0.44

164

500

Other and unspecified polyneuropathies, also in other diseases

136

373

3.69

42.57

1.3

1.2

30.43

22.71

u/l

0.93

117

310

Malignant neoplasm, wide definition for exclusion

434

1199

2.13

42.25

1.3

1.2

27.32

21.87

u/l

1.01

382

1028

Covid-19 confirmed case

219

803

2.75

41.98

1.4

1.2

32.97

23.37

u/l

2.09

200

670

Asthma, unspecified (mode), excluding more controls

260

755

2.59

41.59

1.3

1.2

24.60

15.29

u/l

2.25

223

639

Biological medication for rheuma

129

347

3.76

41.54

1.2

18.99

21.23

u/l

0.23

116

296

Medical observation and evaluation for suspected diseases and conditions

326

688

2.43

41.26

1.3

1.2

21.63

24.15

u/l

0.45

282

590

Complications of medical and surgical care

399

1760

2.09

41.02

1.3

1.2

33.41

23.24

u/l

2.38

347

1512

Gout, unspecified

135

378

3.61

40.98

1.2

1.3

33.93

26.69

u/l

0.67

121

305

Asthma, excluding more controls

351

788

2.33

40.85

1.3

1.2

28.46

14.98

u/l

3.25

304

669

Other heart diseases, wide

449

1337

2.06

40.61

1.3

1.2

26.03

21.80

u/l

1.09

396

1147

Diseases of the digestive system

267

1091

2.45

40.54

1.3

1.2

35.82

23.95

u/l

2.14

242

921

Polyneuropathies and other disorders of the peripheral nervous system

148

444

3.37

40.40

1.3

1.2

31.09

22.39

u/l

1.22

128

363

Any event in cancer register

443

1262

2.07

40.38

1.3

1.2

27.15

21.41

u/l

1.01

388

1085

Codeine or tramadol medication

554

1586

1.92

39.92

1.2

23.45

24.98

u/l

0.30

463

1383

Peripheral artery operations in Hilmo

222

4.47

39.80

1.3

1.2

38.00

24.12

u/l

1.59

186

Ascites

139

5.58

39.73

1.3

1.2

48.43

22.98

u/l

1.72

120

Persons encountering health services in other circumstances, wide

570

1545

1.91

39.70

1.2

25.42

24.91

u/l

0.08

502

1320

Solid cancers, helper endpoint

415

1167

2.11

39.44

1.3

1.2

23.81

21.72

u/l

0.30

364

999

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

339

1541

2.18

39.29

1.3

1.2

29.04

23.20

u/l

1.03

293

1316

Atherosclerosis, excluding cerebral and coronary sclerosis

235

717

2.61

38.78

1.2

1.3

31.17

26.63

u/l

0.77

209

600

Diabetes, varying definitions

507

1535

1.94

38.66

1.3

1.2

26.18

22.44

u/l

0.90

451

1312

Other diseases of intestine

110

279

3.99

38.54

1.3

1.2

36.59

19.65

u/l

1.27

234

Cardiovascular diseases

259

536

2.61

38.28

1.2

20.47

17.50

u/l

0.40

230

461

Oxycodone

213

724

2.68

38.11

1.5

1.2

45.48

21.58

u/l

4.89

195

616

Sulfasalazine

172

584

2.97

38.09

1.3

1.2

19.38

19.64

u/l

0.02

154

496

Pain, not elsewhere classified

166

553

3.02

38.01

1.3

1.2

31.76

18.23

u/l

1.99

149

466

Certain infectious and parasitic diseases

335

729

2.31

37.78

1.3

1.2

27.15

16.30

u/l

2.27

284

621

Infections of the skin and subcutaneous tissue

302

1337

2.25

37.71

1.3

1.2

30.20

23.01

u/l

1.57

269

1139

Tumor necrosis factor alpha inhibitors

115

306

3.80

37.67

1.2

17.77

22.25

u/l

0.52

103

263

Codes for special purposes

280

1215

2.31

37.45

1.3

1.2

29.22

22.73

u/l

1.62

257

1030

Diarrhoea and gastroenteritis of presumed infectious origin

495

1709

1.92

37.25

1.3

1.2

27.02

23.46

u/l

0.70

433

1472

Other diseases of biliary tract

159

5.06

37.11

1.4

1.2

39.14

18.04

u/l

1.38

135

Chronic gastritis

177

620

2.88

37.08

1.2

29.41

25.49

u/l

0.44

150

520

Diabetes mellitus

503

1539

1.92

36.88

1.2

26.26

22.42

u/l

0.93

447

1316

Certain disorders involving the immune mechanism

136

411

3.35

36.75

1.3

1.2

23.63

22.79

u/l

0.08

124

344

Glomerulonephritis

168

4.90

36.73

1.3

1.2

25.35

19.40

u/l

0.61

139

Other soft tissue disorders, not elsewhere classified

447

1320

1.99

36.57

1.2

26.80

23.93

u/l

0.48

381

1144

Provisional assignment of new diseases of uncertain etiology

278

1216

2.29

36.51

1.3

1.2

29.24

22.74

u/l

1.61

255

1031

Disorders of mineral metabolism

139

5.34

36.51

1.4

1.1

32.84

23.31

u/l

0.58

113

Hypertensive heart and/or renal disease

151

349

3.25

36.19

1.2

1.3

36.77

23.38

u/l

2.31

138

295

Other noninfective gastroenteritis and colitis

155

516

3.03

35.54

1.3

1.2

26.33

21.73

u/l

0.54

132

429

Bacterial pneumoniae

220

765

2.55

35.54

1.3

1.2

33.12

21.15

u/l

2.99

201

644

Rheumatoid arthritis

200

678

2.66

35.38

1.2

1.3

22.53

24.53

u/l

0.28

178

578

Bacterial pneumonia, not elsewhere classified

212

726

2.59

35.25

1.3

1.2

34.01

21.55

u/l

2.99

193

607

Hyperkalaemia

7.11

35.23

1.3

37.87

20.40

u/l

1.35

Low back pain

374

1309

2.06

35.15

1.3

1.2

27.49

23.58

u/l

0.71

331

1132

Asthma (only as main-diagnosis), excluding more controls

311

788

2.26

34.95

1.3

1.2

27.75

14.98

u/l

3.06

277

669

Asthma

361

884

2.15

34.94

1.3

1.2

29.03

16.85

u/l

2.81

312

753

Other specific joint derangements/joint disorders

343

1039

2.14

34.80

1.2

1.3

20.84

25.32

u/l

0.81

294

904

Heart failure and coronary heart disease

243

704

2.46

34.59

1.2

37.07

26.30

u/l

2.18

216

587

Asthma, unspecified (mode)

263

846

2.35

34.52

1.3

1.2

24.46

17.15

u/l

1.58

226

719

Follow-up examination after treatment for conditions other than malignant neoplasms

232

609

2.53

34.52

1.3

1.2

23.95

23.10

u/l

0.07

200

520

Continuous positive airway pressure

118

277

3.62

34.42

1.2

1.3

39.91

17.79

u/l

3.14

108

228

Acute peritonitis

101

6.06

34.23

1.3

1.2

25.65

17.21

u/l

0.89

Cholelithiasis, broad definition with cholecystitis

429

1490

1.94

33.95

1.2

31.18

21.97

u/l

1.98

372

1271

Explicit bacterial Sepsis

160

4.81

33.84

1.5

1.2

29.25

16.01

u/l

1.65

136

Streptococcal septicaemia

124

5.40

33.50

1.5

1.1

31.90

15.77

u/l

1.77

102

Hypothyroidism (congenital or acquired)

112

4.76

33.48

1.2

31.86

12.06

u/l

1.67

Pure hypercholesterolaemia

370

1188

2.04

33.26

1.2

26.44

24.38

u/l

0.29

323

1004

Adalimumab

159

4.78

33.16

1.1

18.24

27.22

u/l

0.66

135

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

466

1490

1.89

33.12

1.2

30.97

22.82

u/l

2.22

410

1271

COPD/asthma related infections

485

1286

1.89

33.10

1.3

1.2

25.18

19.00

u/l

1.61

424

1098

COPD/asthma/ILD related infections

485

1286

1.89

33.10

1.3

1.2

25.18

19.00

u/l

1.61

424

1098

Medicines for HER+ breast cancer

240

977

2.35

32.81

1.2

15.92

23.26

u/l

1.55

214

829

Neoplasms

309

738

2.23

32.70

1.2

22.68

20.53

u/l

0.24

265

646

Liquid cancers, helper endpoint

202

695

2.55

32.61

1.2

39.48

22.45

u/l

2.98

180

586

L02BG Aromatase inhibitors

211

862

2.47

32.53

1.2

13.31

24.11

u/l

4.93

189

725

Alcoholic liver disease

158

4.75

32.45

1.2

45.12

17.36

u/l

2.68

131

Spondyloarthritis

108

305

3.57

32.43

1.2

35.99

19.95

u/l

1.52

253

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

306

1463

2.10

32.31

1.3

1.2

30.13

23.43

u/l

1.10

263

1250

Diseases of the skin and subcutaneous tissue

459

1208

1.91

32.21

1.3

1.2

23.76

23.06

u/l

0.09

394

1038

Cutaneous abscess, furuncle and carbuncle

153

536

2.88

32.12

1.3

1.2

28.42

21.13

u/l

0.95

137

454

Diabetes medication

496

1610

1.83

31.94

1.3

1.2

28.79

22.22

u/l

1.89

435

1382

GI-bleeding

180

695

2.61

31.30

1.2

36.16

26.93

u/l

1.07

161

574

Asthma (mode)

346

893

2.08

31.22

1.3

1.2

28.85

16.93

u/l

2.71

299

761

Cholelithiasis

410

1482

1.91

31.19

1.2

30.98

21.99

u/l

1.86

354

1265

Hernia of abdominal wall, postoperative

240

3.86

31.02

1.3

1.1

41.40

15.44

u/l

2.01

195

Haemorrhage from respiratory passages

193

691

2.53

31.00

1.2

33.33

24.10

u/l

1.35

168

583

Diabetes, insulin treatment (Kela reimbursement)

491

1637

1.82

30.96

1.3

1.2

30.61

22.97

u/l

2.16

433

1401

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

213

538

2.51

30.81

1.3

1.2

26.88

19.18

u/l

1.34

186

459

Personal history of malignant neoplasm

134

5.02

30.77

1.2

1.1

17.60

19.35

u/l

0.09

115

Non-ischemic cardiomyopathy

179

547

2.65

30.70

1.2

1.3

27.69

24.41

u/l

0.42

156

457

Hypothyroidism and >3 levothyroxin purchases

112

4.56

30.65

1.2

31.49

12.06

u/l

1.54

Hypothyroidism, levothyroxine purchases

112

4.56

30.65

1.2

31.49

12.06

u/l

1.54

Fracture of femur

161

536

2.74

30.32

1.3

1.2

29.17

26.46

u/l

0.23

139

441

Other retinal disorders

332

1285

2.02

30.29

1.3

1.2

28.52

25.77

u/l

0.40

281

1112

Fall on same level

520

1596

1.78

30.15

1.3

1.2

25.79

22.80

u/l

0.60

437

1397

Pleural effusion

103

299

3.48

29.75

1.2

50.42

23.50

u/l

1.90

249

Bacterial pneumonia (organism specified)

233

933

2.28

29.62

1.3

1.2

32.84

23.44

u/l

2.17

214

783

Other diseases of the digestive system

178

703

2.55

29.59

1.2

36.11

26.61

u/l

1.12

161

578

249

3.73

29.50

1.3

1.2

25.02

21.17

u/l

0.26

211

Ulcerative rectosigmoiditis

120

5.15

29.45

1.5

1.1

28.33

16.37

u/l

0.46

Diaphragmatic hernia

219

953

2.31

29.42

1.2

26.19

23.25

u/l

0.30

180

808

Congenital malformations of the urinary system

5.87

29.33

1.4

1.2

26.29

16.18

u/l

1.07

Asthma (only as main-diagnosis)

317

884

2.08

29.28

1.3

1.2

27.58

16.85

u/l

2.36

281

753

Lower back pain or/and sciatica

492

1815

1.78

29.27

1.3

1.2

27.90

23.54

u/l

0.97

427

1567

Artificial opening status

6.14

28.96

1.3

1.2

62.55

18.22

u/l

1.96

Disorders of choroid and retina

403

1538

1.87

28.77

1.3

1.2

26.69

25.17

u/l

0.23

337

1330

Crohn disease (strict definition, all UC cases excluded)

6.17

28.50

1.3

1.1

13.67

15.39

u/l

0.16

Type 2 diabetes, wide definition

395

1345

1.89

28.39

1.2

28.89

22.30

u/l

1.55

346

1137

Abnormalities of breathing

399

1230

1.89

28.22

1.2

30.73

22.54

u/l

1.94

346

1058

Systemic connective tissue disorders

207

896

2.33

28.18

1.3

1.2

28.83

21.69

u/l

0.99

180

759

Cardiac arrhythmias

272

826

2.15

27.99

1.3

1.2

24.20

19.78

u/l

0.83

242

707

Other diseases of urinary system

461

1443

1.80

27.83

1.2

24.51

23.35

u/l

0.18

394

1252

Other diseases of blood and blood-forming organs, wide

141

512

2.78

27.79

1.2

32.68

22.38

u/l

1.20

128

426

Dyspnoea

429

1763

1.80

27.62

1.2

30.05

23.88

u/l

1.63

372

1515

Congenital malformations of the urinary system

101

5.44

27.62

1.4

1.2

26.15

15.82

u/l

1.15

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

4.99

27.60

1.1

1.3

40.15

19.41

u/l

1.29

Benign neoplasm of colon, rectum, anus and anal canal

326

1456

1.95

27.60

1.2

30.72

24.54

u/l

0.88

275

1240

Viral pneumonia

215

3.85

27.54

1.4

1.2

32.13

18.10

u/l

1.81

181

Seropositive rheumatoid arthritis

153

582

2.64

27.30

1.2

22.07

21.67

u/l

0.05

138

495

Type 2 diabetes

455

1491

1.79

27.10

1.2

26.18

22.89

u/l

0.71

403

1272

Asthma-related pneumonia or sepsis

201

872

2.31

27.09

1.3

1.2

40.15

23.45

u/l

2.03

175

737

Asthma, hospital admissions 3, pneumonia

201

872

2.31

27.09

1.3

1.2

40.15

23.45

u/l

2.03

175

737

Polycystic kidney disease

8.26

27.01

1.3

1.1

28.43

14.34

u/l

1.69

Constipation

431

1668

1.79

26.93

1.3

1.2

27.76

24.29

u/l

0.57

370

1437

Nausea and vomiting

155

587

2.60

26.87

1.3

1.2

32.22

21.40

u/l

1.50

139

486

Asthma-related pneumonia

200

871

2.31

26.72

1.3

1.2

40.17

23.48

u/l

2.01

174

736

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

331

1554

1.91

26.58

1.2

30.91

24.18

u/l

1.16

284

1319

Rheumatoid arthritis, including avohilmo

219

996

2.21

26.53

1.2

21.90

23.10

u/l

0.18

192

839

Atrial fibrillation and flutter

162

397

2.66

26.52

1.3

1.2

25.78

19.61

u/l

1.04

148

332

Disorders of thyroid, IBD co-morbidities

157

3.87

26.19

1.1

1.4

22.94

23.57

u/l

0.03

136

Paralytic ileus and intestinal obstruction

144

545

2.66

26.15

1.4

1.2

42.59

22.80

u/l

2.06

126

456

Other CVD (FINNGEN)

127

4.38

26.06

1.5

1.3

26.06

21.16

u/l

0.38

105

Depression

440

1705

1.75

25.40

1.2

25.01

22.88

u/l

0.35

380

1471

Asthma-related infections

287

1435

1.97

25.39

1.3

1.2

33.20

22.54

u/l

1.71

253

1230

Asthma, hospital admission 2, infections

287

1435

1.97

25.39

1.3

1.2

33.20

22.54

u/l

1.71

253

1230

Benign neoplasm: Colon

281

1359

1.98

25.36

1.2

29.67

25.04

u/l

0.56

235

1158

Pain in throat and chest

372

1206

1.86

25.25

1.2

25.13

22.88

u/l

0.36

323

1035

Fungal Sepsis

6.55

25.25

1.6

1.1

65.17

14.73

u/l

2.73

Other ulcerative colitis

5.54

25.10

1.4

1.1

42.50

16.53

u/l

0.84

Diverticular disease of intestine

341

1153

1.89

24.92

1.2

24.71

23.22

u/l

0.21

287

989

Hypothyroidism, drug reimbursement

5.01

24.90

1.2

34.50

11.07

u/l

1.79

Cystic kidney disease

6.64

24.84

1.3

1.2

26.91

19.11

u/l

0.73

Antihypertensive medication - note that there are other indications

236

567

2.21

24.83

1.2

1.3

23.10

17.69

u/l

0.60

210

487

Cystitis

399

1316

1.81

24.81

1.2

22.95

22.92

u/l

0.00

335

1139

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

135

4.51

24.76

1.4

1.2

26.24

18.02

u/l

0.95

114

Diabetic retinopathy, excluding more controls

155

326

2.69

24.69

1.4

1.2

28.67

26.05

u/l

0.24

135

285

Other nutritional deficiencies

308

1529

1.90

24.62

1.3

1.2

21.59

22.58

u/l

0.17

265

1314

Diseases of peritoneum

196

3.82

24.57

1.3

1.2

24.85

19.84

u/l

0.44

164

Statin medication

306

874

1.97

24.47

1.2

25.22

23.90

u/l

0.13

259

768

Speech therapy

157

641

2.47

24.46

1.2

26.49

22.73

u/l

0.28

132

534

Cystic kidney disease

6.52

24.45

1.3

1.2

26.91

19.11

u/l

0.74

Other systemic involvement of connective tissue (FG)

147

574

2.54

24.40

1.2

29.59

23.31

u/l

0.54

127

487

Other bacterial intestinal infections

107

360

3.00

24.31

1.3

1.2

37.48

22.46

u/l

1.74

303

Disorder of lipoprotein metabolism, unspecified

230

3.56

24.27

1.3

1.2

32.90

24.13

u/l

0.55

189

Excluding asthma or asthma-COPD overlap

341

895

1.91

24.21

1.2

25.32

16.74

u/l

1.84

296

764

Spondylopathies

373

1221

1.83

24.19

1.2

27.38

24.87

u/l

0.34

317

1052

Chronic pancreatitis

226

3.58

24.17

1.3

1.2

38.35

21.80

u/l

1.31

191

Viral pneumonia (unknown virus, not influenza)

103

5.02

23.95

1.3

1.2

42.56

16.27

u/l

2.65

Gastro-oesophageal reflux disease

312

1432

1.89

23.93

1.3

1.2

23.89

25.25

u/l

0.17

265

1235

UC patients in KELA-register (code 208), prior to 1994

5.77

23.88

1.6

1.2

11.41

17.11

u/l

1.23

Implicit fungal Sepsis

111

4.85

23.87

1.5

1.2

55.53

13.43

u/l

2.94

COPD differential diagnosis

339

893

1.91

23.83

1.2

25.82

16.93

u/l

1.92

295

761

ILD differential diagnosis

339

893

1.91

23.82

1.2

25.82

16.93

u/l

1.92

295

761

Mood disorders

465

1782

1.69

23.52

1.2

25.75

23.28

u/l

0.43

403

1536

Cardiomyopathy

289

3.21

23.50

1.2

1.3

33.48

22.78

u/l

1.46

241

Other diseases of pancreas

146

4.24

23.29

1.3

1.2

37.35

20.06

u/l

0.89

128

Mood [affective] disorders

463

1781

1.69

23.25

1.2

25.60

23.28

u/l

0.39

401

1536

Other pulmonary diagnosis

337

895

1.89

23.15

1.3

1.2

25.92

16.74

u/l

1.98

291

764

Peripheral arterial reconstruction

328

3.04

23.13

1.3

28.67

25.60

u/l

0.33

272

All influenza

126

476

2.66

23.04

1.4

1.2

30.56

20.76

u/l

1.29

114

398

Noninfectious colitis NAS

248

3.38

23.01

1.3

1.1

27.04

18.69

u/l

0.74

203

Injuries to the hip and thigh

240

1075

2.03

23.00

1.3

1.2

28.94

24.77

u/l

0.56

205

913

Dorsalgia

433

1345

1.73

22.68

1.2

23.32

23.84

u/l

0.08

376

1168

Hypokalaemia

213

3.56

22.50

1.3

1.2

27.68

22.82

u/l

0.39

175

Symptoms and signs involving cognition, perception, emotional state and behaviour

437

1765

1.69

22.35

1.2

24.81

24.86

u/l

0.01

370

1539

Total colectomy operation

5.92

22.33

1.7

1.1

29.06

17.78

u/l

0.53

Total colectomy

5.92

22.33

1.7

1.1

29.06

17.78

u/l

0.53

Cholecystectomy

347

1683

1.78

22.31

1.2

27.69

23.93

u/l

0.50

302

1439

Fracture of lumbar spine and pelvis

124

472

2.64

22.31

1.3

1.2

34.72

25.81

u/l

0.57

109

387

Collagenous colitis

164

3.95

22.30

1.3

1.1

29.16

20.08

u/l

0.75

138

Other diseases of pleura

220

933

2.08

22.27

1.3

1.2

49.57

24.63

u/l

3.85

192

783

Injuries to the abdomen, lower back, lumbar spine and pelvis

195

899

2.16

22.25

1.3

1.2

29.63

23.38

u/l

0.64

172

749

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

140

259

2.72

22.17

1.1

25.31

12.09

u/l

1.40

120

213

L04AC Interleukin inhibitors

5.13

22.15

1.1

25.15

18.17

u/l

0.46

Arthropathies

378

1071

1.79

22.09

1.2

1.3

19.82

25.65

u/l

1.60

332

934

Other gastritis (incl. Duodenitis)

124

476

2.62

22.02

1.3

1.2

24.10

24.86

u/l

0.07

109

394

Other functional intestinal disorders

215

968

2.07

21.82

1.3

1.2

31.90

22.05

u/l

1.47

193

827

Nephrotic syndrome

6.65

21.82

1.3

1.2

25.07

18.87

u/l

0.38

Headache

270

1124

1.92

21.76

1.3

1.2

22.93

18.41

u/l

0.74

240

962

Abdominal and pelvic pain

425

1241

1.72

21.75

1.2

26.88

23.00

u/l

0.66

369

1062

Other bacterial intestinal infections

125

485

2.59

21.73

1.3

1.2

38.07

23.57

u/l

1.69

108

408

Vitreous haemorrhage

190

3.68

21.71

1.4

1.2

27.22

19.78

u/l

0.85

158

Iron deficiency anaemia secondary to blood loss (chronic)

320

2.99

21.60

1.3

1.2

31.45

19.62

u/l

1.09

271

Cellulitis

119

454

2.64

21.41

1.4

1.2

31.91

21.68

u/l

1.35

110

383

Other diseases of arteries and capillaries

170

3.81

21.22

1.4

1.2

42.61

15.60

u/l

1.61

145

Ulcerative proctitis

5.01

21.13

1.6

1.1

14.51

16.23

u/l

0.18

Bacterial intestinal infections, IBD co-morbidities

108

395

2.76

21.12

1.3

1.2

38.04

23.88

u/l

1.61

325

Mood disorders, excluding more controls

423

1497

1.69

21.04

1.2

1.3

26.85

23.25

u/l

0.63

363

1306

Other or unspecified ileus, impaction or obstruction

101

357

2.85

21.03

1.5

1.2

47.06

24.13

u/l

1.69

290

Symptoms and signs involving the digestive system and abdomen

422

1241

1.71

20.90

1.2

26.86

23.00

u/l

0.63

366

1062

Hypertensive Heart Disease

113

324

2.75

20.81

1.2

1.3

37.24

24.38

u/l

1.96

102

275

Valvular heart disease excluding rheumatic fever

214

749

2.07

20.75

1.3

1.2

28.72

22.03

u/l

1.10

184

627

Asthma (diagnoses ohter than nonallergic)

389

1914

1.69

20.59

1.3

1.2

25.53

24.06

u/l

0.22

335

1657

210

1030

2.03

20.53

1.3

1.2

30.76

20.63

u/l

1.34

189

872

Use of hypnotics and sedatives

465

1631

1.64

20.48

1.3

1.2

28.31

23.80

u/l

0.87

393

1419

Psoriatic and enteropathic arthropathies

203

3.48

20.38

1.2

14.70

18.32

u/l

0.52

173

Non-rheumatic valve diseases

212

744

2.06

20.38

1.3

1.2

28.94

22.07

u/l

1.12

182

622

Anxiety (asthma-related co-morbidities)

266

1092

1.89

20.24

1.2

1.3

19.92

21.72

u/l

0.24

228

940

Enterocolitis due to Clostridium difficile

195

3.52

20.15

1.3

1.2

40.52

23.10

u/l

1.47

162

Other CVD

106

395

2.70

20.01

1.4

1.2

25.20

28.11

u/l

0.26

325

Dermatitis and eczema

484

1871

1.61

19.97

1.3

1.2

26.03

24.22

u/l

0.26

423

1618

Gingivitis and periodontal diseases

441

1373

1.66

19.90

1.3

1.2

23.93

25.64

u/l

0.24

384

1168

Hyperlipidaemia, other/unspecified

182

792

2.13

19.83

1.2

28.78

23.93

u/l

0.49

158

670

Atrial fibrillation and flutter with reimbursement

129

321

2.57

19.80

1.2

21.61

20.15

u/l

0.18

114

268

Periodontitis

434

1773

1.64

19.77

1.3

1.2

24.99

24.61

u/l

0.05

378

1524

L02BA Anti-estrogens

113

438

2.60

19.77

1.2

17.42

20.02

u/l

0.18

101

370

Other disorders of urethra and urinary system

316

1282

1.78

19.77

1.3

1.2

26.90

23.06

u/l

0.64

270

1106

Other systemic involvement of connective tissue

152

676

2.26

19.61

1.2

29.26

22.32

u/l

0.67

132

566

Methotrexate

274

3.05

19.59

1.1

23.76

18.94

u/l

0.52

232

Primary_lymphoid and hematopoietic malignant neoplasms

127

524

2.44

19.45

1.2

44.17

24.44

u/l

2.29

115

435

Intestinal stricture

162

744

2.19

19.32

1.3

1.2

40.19

24.31

u/l

1.67

139

615

Other necrotizing vasculopathies

128

4.12

19.19

1.3

1.1

25.07

18.49

u/l

0.68

109

Benign neoplasm of other and ill-defined parts of digestive system

108

416

2.62

19.14

1.3

1.2

26.56

22.10

u/l

0.45

100

347

Benign neoplasms

400

1317

1.68

19.07

1.2

22.02

25.52

u/l

0.61

337

1152

Obesity, other/unspecified

166

775

2.15

19.00

1.2

18.46

21.02

u/l

0.48

149

661

Obesity

278

1492

1.80

18.98

1.2

1.3

21.00

22.89

u/l

0.36

239

1287

Obesity and other hyperalimentation

279

1497

1.80

18.97

1.2

1.3

20.92

22.87

u/l

0.38

240

1292

Disorders of lens

324

1152

1.76

18.85

1.3

1.2

29.49

22.87

u/l

1.23

293

975

Cerebrovascular diseases (FINNGEN)

141

423

2.37

18.83

1.3

1.2

27.52

21.20

u/l

0.65

123

357

Symptoms and signs involving the circulatory and respiratory systems

411

1236

1.67

18.82

1.2

25.17

22.48

u/l

0.52

358

1063

Viral and other specified intestinal infections

117

455

2.49

18.69

1.3

1.2

37.52

18.49

u/l

2.25

107

390

Chronic periodontitis, including avohilmo

429

1778

1.62

18.67

1.3

1.2

24.92

24.61

u/l

0.04

373

1529

494

1613

1.59

18.60

1.3

1.2

27.90

22.26

u/l

1.19

437

1387

Vascular disorders of the intestines

114

4.26

18.55

1.4

1.3

22.30

22.36

u/l

0.00

Gingival hyperplasia

5.59

18.43

1.4

1.2

28.37

16.58

u/l

0.78

Gastroduodenal ulcer

125

524

2.39

18.38

1.2

29.78

28.53

u/l

0.08

107

438

Acute pancreatitis

102

390

2.63

18.35

1.2

49.26

21.27

u/l

1.96

328

Parasetamol

295

822

1.82

18.31

1.2

25.15

20.87

u/l

0.49

252

725

Diabetic retinopathy, strict definition

107

366

2.61

18.29

1.4

1.2

30.55

31.07

u/l

0.04

319

Cardiodefibrillation

170

812

2.10

18.25

1.2

1.3

25.37

26.85

u/l

0.22

147

683

Depression medications

121

3.37

18.23

1.1

1.2

32.45

11.48

u/l

1.24

103

Seropositive rheumatoid arthritis, wide

153

704

2.19

18.22

1.2

22.07

23.58

u/l

0.19

138

593

Anxiety disorders, excluding more controls

361

1397

1.69

18.17

1.2

1.3

21.79

22.13

u/l

0.04

309

1212

Viral and other specified intestinal infections

300

2.84

18.10

1.3

1.2

40.41

17.29

u/l

2.28

258

Diabetic maculopathy, excluding more controls

175

3.52

18.10

1.4

1.2

32.02

22.22

u/l

0.59

144

Abnormal results of function studies

152

3.72

18.05

1.3

1.1

23.96

14.88

u/l

1.66

128

Primary hyperparathyroidism

256

3.04

18.03

1.2

12.77

20.57

u/l

1.67

222

Diseases of the musculoskeletal system and connective tissue

199

480

2.08

18.00

1.2

1.3

20.62

24.77

u/l

0.45

166

424

Other/unspecified seropositive rheumatoid arthritis

151

695

2.19

17.97

1.2

22.22

23.27

u/l

0.13

136

585

Syncope and collapse

189

806

2.01

17.72

1.3

1.2

39.71

20.76

u/l

2.69

163

681

Other medical care

202

931

1.96

17.63

1.5

1.2

42.14

22.29

u/l

3.56

187

783

Other disorders of glucose regulation and pancreatic internal secretion

132

3.90

17.58

1.4

1.1

38.07

15.72

u/l

1.62

113

Other diseases of stomach and duodenum

119

4.09

17.57

1.2

1.1

34.93

18.91

u/l

1.18

100

Hypo-osmolality and hyponatraemia

351

2.68

17.53

1.1

1.2

29.55

26.03

u/l

0.29

283

Hypothyroidism, strict autoimmune

261

940

1.83

17.50

1.2

26.60

23.63

u/l

0.32

227

783

Chronic periodontitis, complicated

253

1396

1.80

17.37

1.4

1.2

27.97

24.92

u/l

0.37

219

1187

All anxiety disorders

266

1174

1.80

17.37

1.2

19.92

21.38

u/l

0.19

228

1015

Coagulation defects, purpura and other haemorrhagic conditions

104

413

2.54

17.35

1.3

1.2

27.74

24.15

u/l

0.34

351

Immunodeficiencies

4.89

17.34

1.3

1.1

20.52

17.09

u/l

0.37

Other antidepressants

431

1374

1.61

17.31

1.2

1.3

24.99

24.77

u/l

0.03

359

1203

Abnormalities of gait and mobility

247

3.03

17.21

1.2

30.85

22.23

u/l

0.54

212

Pain (limb, back, neck, head abdominally)

286

796

1.80

17.18

1.2

24.86

24.89

u/l

0.00

244

685

Bronchitis

459

1850

1.57

17.15

1.3

1.2

28.69

23.14

u/l

1.12

404

1594

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

147

683

2.17

17.12

1.2

21.86

22.94

u/l

0.13

132

575

Other necrotizing vasculopathies (FG)

4.70

17.05

1.4

1.1

21.47

16.75

u/l

0.35

Benzodiazepine use

431

1882

1.58

17.03

1.2

25.47

24.55

u/l

0.13

363

1640

Invasive ventilation

123

3.95

16.81

1.2

42.10

18.81

u/l

1.25

107

Enlarged lymph nodes

299

2.79

16.80

1.3

1.2

32.53

20.65

u/l

1.00

249

Diabetic retinopathy

184

564

2.05

16.77

1.3

1.2

27.58

30.52

u/l

0.36

161

498

Presence of cardiac and vascular implants and grafts

199

760

1.95

16.66

1.2

35.87

27.06

u/l

1.30

172

635

Symptoms and signs concerning food and fluid intake

170

3.44

16.63

1.3

1.1

24.54

24.44

u/l

0.01

143

Diseases of the eye and adnexa

321

938

1.72

16.39

1.2

18.52

25.26

u/l

1.90

283

814

Neurotic, stress-related and somatoform disorders

382

1664

1.61

16.38

1.2

21.70

23.38

u/l

0.27

328

1437

Anxiety disorders

386

1679

1.61

16.37

1.2

21.57

23.27

u/l

0.28

332

1451

Other external causes of accidental injury

334

988

1.70

16.33

1.3

1.2

22.75

u/l

0.00

289

863

Complications of internal orthopaedic prosthetic devices, implants and grafts

118

511

2.32

16.31

1.3

1.2

30.84

24.91

u/l

0.59

422

Volume depletion

144

3.64

16.30

1.3

1.2

39.28

22.43

u/l

0.90

115

Hypotension

327

2.68

16.25

1.4

1.2

27.58

25.62

u/l

0.15

271

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

416

1693

1.58

16.11

1.3

1.2

26.68

24.87

u/l

0.31

362

1454

Sequelae of external causes of morbidity and mortality

134

616

2.19

16.06

1.2

27.56

23.33

u/l

0.43

116

515

Chronic tubulo-interstitial nephritis

5.01

15.97

1.3

1.2

18.14

16.08

u/l

0.19

Vitamin B12 deficiency anaemia

180

3.31

15.95

1.3

1.2

24.76

21.09

u/l

0.27

152

Other disorders of white blood cells

4.44

15.92

1.1

1.2

46.55

16.23

u/l

1.32

Cough

190

939

1.92

15.89

1.2

21.02

21.01

u/l

0.00

168

795

Other respiratory diseases principally affecting the interstitium

366

2.56

15.85

1.1

1.2

39.06

24.94

u/l

1.14

303

Mycoses

131

603

2.18

15.65

1.4

1.2

44.04

20.15

u/l

2.33

117

502

Paroxysmal tachycardia

327

2.52

15.63

1.5

1.2

27.92

21.53

u/l

0.47

276

Malignant neoplasm of breast, HER-negative

112

474

2.34

15.61

1.3

1.2

19.89

19.78

u/l

0.01

401

Open wound of lower leg

295

2.73

15.53

1.4

1.2

25.72

25.70

u/l

0.00

251

Falls/tendency to fall

435

1394

1.57

15.53

1.3

1.2

24.86

22.50

u/l

0.44

370

1214

Accidents

330

988

1.68

15.48

1.3

1.2

25.15

22.75

u/l

0.28

284

863

AV-block

256

2.75

15.35

1.2

31.72

24.69

u/l

0.73

213

Chronic apical periodontitis

464

1733

1.53

15.31

1.2

27.10

23.96

u/l

0.56

395

1503

Acute pancreatitis (for exclusion)

102

427

2.40

15.25

1.2

49.26

22.77

u/l

1.79

355

Other acute lower respiratory infections

225

1198

1.80

15.24

1.3

1.2

32.68

23.53

u/l

1.09

198

1021

Hypoglycaemia, other or unspecified

105

4.04

15.22

1.4

1.1

42.78

15.20

u/l

1.66

Other anxiety disorders

194

894

1.89

15.16

1.2

20.10

19.74

u/l

0.03

164

776

Depression or dysthymia

292

945

1.71

15.06

1.2

1.3

26.92

25.09

u/l

0.21

246

822

Other/unspecified dorsalgia

172

881

1.94

15.01

1.2

22.22

21.77

u/l

0.05

143

743

Spondylopathies (FG)

225

2.95

14.83

1.1

1.2

23.98

22.15

u/l

0.08

193

Other dorsopathies, not elsewhere classified

404

1349

1.57

14.80

1.2

24.33

23.79

u/l

0.07

350

1171

Malignant neoplasm of breast, ER-negative, including Hilmo

119

513

2.22

14.74

1.3

1.2

20.17

20.96

u/l

0.05

100

434

Need for other prophylactic measures

4.09

14.72

1.1

1.2

12.41

15.81

u/l

0.72

Soft tissue disorders

407

1340

1.57

14.72

1.3

1.2

21.41

23.96

u/l

0.48

348

1163

Dermatitis

268

1587

1.69

14.71

1.3

1.2

26.06

23.10

u/l

0.41

225

1356

Irritable bowel syndrome

128

599

2.15

14.70

1.2

20.28

19.89

u/l

0.04

111

513

Colectomy operation

364

2.49

14.54

1.4

1.2

39.08

25.60

u/l

0.99

308

Other joint disorders

332

1070

1.64

14.53

1.2

1.3

19.46

25.68

u/l

1.69

289

933

Fracture of rib(s), sternum and thoracic spine

136

655

2.09

14.50

1.3

1.2

27.61

26.05

u/l

0.11

114

544

Acute bronchitis

181

946

1.88

14.37

1.3

1.2

30.31

23.62

u/l

0.77

161

798

Conduction disorders

126

472

2.17

14.35

1.2

30.05

23.05

u/l

1.07

114

388

Mycoses

355

1970

1.57

14.33

1.3

1.2

30.51

22.91

u/l

1.30

311

1702

Other and unspecified dermatitis

227

1300

1.75

14.29

1.2

26.04

23.23

u/l

0.34

193

1103

Calcific aortic valvular stenosis, diagnosis (helper)

132

613

2.10

14.20

1.3

1.2

31.88

28.63

u/l

0.40

119

507

Operations 2 for CAVS

132

613

2.10

14.20

1.3

1.2

31.88

28.63

u/l

0.40

119

507

Other cataract

211

885

1.81

14.17

1.3

1.2

23.66

23.06

u/l

0.08

185

742

Calcific aortic valvular stenosis

132

614

2.09

14.15

1.3

1.2

31.88

28.61

u/l

0.40

119

508

Calcific aortic valvular stenosis, operated

132

614

2.09

14.15

1.3

1.2

31.88

28.61

u/l

0.40

119

508

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

164

853

1.93

14.11

1.2

28.13

22.03

u/l

0.63

141

721

Calcific aortic valvular stenosis, including rheumatic fever

132

615

2.09

14.05

1.3

1.2

31.88

29.12

u/l

0.32

119

509

Any death

280

1205

1.67

13.99

1.4

1.2

48.15

19.59

u/l

7.17

250

1012

All influenza (not pneumonia)

238

2.83

13.99

1.4

1.1

34.70

20.28

u/l

1.09

200

Diabetic neuropathy

260

2.74

13.89

1.3

40.74

27.13

u/l

0.93

225

Injuries to the thorax

193

1063

1.82

13.86

1.2

27.91

25.64

u/l

0.23

165

901

Fracture of lower leg, including ankle

246

1438

1.70

13.85

1.2

25.87

23.79

u/l

0.26

220

1219

Exposure to other specified factors

307

1757

1.61

13.81

1.3

1.2

24.67

23.51

u/l

0.16

263

1517

Abnormal weight loss

161

3.26

13.80

1.3

1.2

22.86

17.05

u/l

0.90

138

Overexertion and strenuous or repetitive movements

187

3.08

13.74

1.3

1.1

29.57

21.81

u/l

0.57

156

Other pleural conditions

187

3.08

13.74

1.3

51.31

23.38

u/l

1.83

157

Intestinal adhesions without obstruction

147

3.37

13.67

1.2

46.91

22.48

u/l

1.36

126

Diagnoses used for exclusion with ILD

123

584

2.12

13.65

1.2

26.99

23.62

u/l

0.38

109

482

Cardiomyopathies, Primary/intrinsic

188

3.05

13.60

1.2

1.3

37.54

20.90

u/l

2.33

155

Symptoms and signs involving the skin and subcutaneous tissue

301

1840

1.60

13.57

1.2

25.24

23.66

u/l

0.19

266

1576

Cardiomyopathy (excluding other)

199

2.99

13.55

1.2

36.94

20.50

u/l

2.37

162

Seronegative rheumatoid arthritis

216

2.89

13.45

1.1

24.75

19.27

u/l

0.62

181

Other reaction to severe stress, and adjustment disorders

155

806

1.93

13.36

1.3

1.2

20.06

19.41

u/l

0.07

139

694

Senile cataract

284

1055

1.65

13.33

1.3

1.2

29.57

23.65

u/l

0.94

258

892

Amiodarone users

191

3.01

13.27

1.1

1.3

29.38

20.72

u/l

1.41

161

Persons with potential health hazards related to communicable diseases

148

753

1.95

13.23

1.3

1.2

25.54

19.20

u/l

0.52

132

655

Sequelae with surgical and medical care as external cause

103

464

2.23

13.08

1.3

1.2

27.79

24.89

u/l

0.22

388

Valvular operations

225

2.82

13.06

1.4

1.3

42.43

22.96

u/l

1.28

188

Injuries to unspecified part of trunk, limb or body region

172

3.11

13.02

1.3

1.2

32.69

15.33

u/l

1.56

151

Psoriasis

137

690

2.00

12.99

1.2

22.00

22.05

u/l

0.00

122

576

Myocardial infarction

213

856

1.76

12.78

1.3

1.2

30.90

25.91

u/l

0.62

181

723

Hard cardiovascular diseases

355

1368

1.55

12.76

1.3

1.2

27.22

23.76

u/l

0.66

316

1168

Cardiac arrest

4.08

12.69

1.3

1.1

44.81

22.05

u/l

0.92

Recurrent or chronic depression

174

659

1.86

12.66

1.2

1.3

27.23

22.31

u/l

0.42

151

573

Asthma, including avohilmo

476

1837

1.46

12.60

1.3

1.2

27.66

23.95

u/l

0.62

407

1597

Viral infections characterized by skin and mucous membrane lesions

351

1967

1.53

12.60

1.2

23.76

24.56

u/l

0.10

305

1701

Persons encountering health services for examination and investigation

237

688

1.73

12.59

1.2

23.17

24.15

u/l

0.08

201

590

Hernia

391

1745

1.50

12.53

1.3

1.2

26.38

24.41

u/l

0.25

334

1509

Benign neoplasm: Stomach

203

2.89

12.52

1.3

1.1

34.75

18.90

u/l

1.24

175

Myocardial infarction, without ST-elevation

172

858

1.83

12.49

1.2

1.3

33.05

27.57

u/l

0.61

149

715

Cyst of kidney

126

3.45

12.48

1.3

1.1

18.92

18.57

u/l

0.02

108

Sciatica+with lumbago

215

1157

1.71

12.46

1.3

1.2

28.31

23.22

u/l

0.70

182

994

Asthma, hospital admissions , main diagnosis only

338

1946

1.54

12.45

1.3

1.2

27.03

23.33

u/l

0.53

298

1679

Acute upper respiratory infections of multiple and unspecified sites

302

1420

1.58

12.27

1.3

1.2

25.26

23.14

u/l

0.32

271

1209

Injuries to the head

447

1882

1.46

12.27

1.2

28.94

23.28

u/l

0.99

373

1644

Seropositive rheumatoid arthritis, strict definition

345

2.39

12.24

1.2

17.53

22.28

u/l

0.64

293

STROKE

229

919

1.70

12.18

1.2

25.53

21.96

u/l

0.52

198

775

Osteoporosis with pathological fracture (FG)

143

3.25

12.18

1.2

1.1

34.89

20.65

u/l

1.17

122

Other (not insulin) diabetes medications

391

1549

1.50

12.10

1.2

29.06

22.75

u/l

1.34

340

1323

Dorsopathies

400

1355

1.50

12.09

1.2

21.55

23.70

u/l

0.38

348

1177

Benign neoplasm: Colon, unspecified

120

593

2.03

12.04

1.2

27.83

24.12

u/l

0.29

496

Sarcoidosis

276

2.56

12.01

1.2

1.1

25.15

20.51

u/l

0.57

232

Hypoparathyroidism

4.36

11.98

1.3

1.2

24.04

14.61

u/l

0.90

Genitourinary diseases

199

558

1.79

11.90

1.2

24.99

22.09

u/l

0.25

171

481

Papulosquamous disorders

176

991

1.78

11.86

1.2

23.33

22.22

u/l

0.12

156

833

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

297

2.46

11.85

1.4

1.2

29.91

22.89

u/l

0.59

254

Injuries to the knee and lower leg

478

1848

1.44

11.79

1.3

1.2

24.13

24.07

u/l

0.01

419

1594

Gastric ulcer

339

2.37

11.75

1.2

33.96

27.38

u/l

0.40

281

Chronic lower respiratory diseases

478

1774

1.44

11.67

1.3

1.2

30.15

23.05

u/l

1.39

411

1540

Factors influencing health status and contact with health services

106

238

2.24

11.63

1.1

20.03

22.42

u/l

0.24

199

Other (seronegative) rheumatoid arthritis, wide

100

468

2.15

11.61

1.2

26.84

22.42

u/l

0.52

387

Weight loss

185

2.89

11.52

1.3

1.1

22.61

16.76

u/l

0.96

158

Diseases of the respiratory system

255

775

1.65

11.49

1.2

26.10

17.26

u/l

1.41

225

660

Non-allergic asthma (mode), excluding more controls

334

2.35

11.40

1.2

31.71

13.52

u/l

1.92

284

Fracture of shoulder and upper arm

163

910

1.80

11.28

1.3

1.2

31.14

22.19

u/l

1.28

138

772

Alcohol use disorder, Swedish definition

210

1151

1.68

11.27

1.2

1.3

33.79

25.55

u/l

1.11

177

997

Other arrhythmias

246

1146

1.62

11.27

1.2

23.74

21.44

u/l

0.38

215

973

221

1212

1.65

11.18

1.2

1.3

32.81

25.41

u/l

1.02

188

1051

Any mental disorder

439

1519

1.45

11.10

1.2

1.3

25.79

23.73

u/l

0.33

371

1326

Dizziness and giddiness

309

1604

1.53

11.10

1.2

24.49

24.82

u/l

0.04

262

1391

Emergency coronary revascularization (for ACS)

359

1461

1.50

11.10

1.2

27.75

24.41

u/l

0.70

313

1248

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

325

2.34

11.08

1.4

1.2

29.00

22.92

u/l

0.52

278

Oesophagitis

3.79

11.03

1.2

1.1

31.46

16.73

u/l

1.05

Early onset COPD, excluding more controls

368

2.26

10.99

1.1

1.2

40.38

15.76

u/l

1.81

308

Trigger finger

338

2.32

10.94

1.3

1.2

23.97

20.97

u/l

0.24

289

Type 2 diabetes, strict (exclude DM1)

372

1476

1.48

10.91

1.2

26.25

23.01

u/l

0.59

326

1254

Personality disorders, excluding more controls

102

494

2.07

10.84

1.1

1.2

22.11

16.73

u/l

0.51

432

Reactive arthropathies

138

3.14

10.82

1.3

1.1

19.26

25.16

u/l

0.36

115

Chronic rhinitis, nasopharyngitis and pharyngitis

146

800

1.83

10.81

1.3

1.2

17.81

19.92

u/l

0.22

124

677

Other special examinations and investigations of persons without complaint or reported diagnosis

227

688

1.67

10.81

1.2

20.10

24.15

u/l

0.77

198

590

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

101

483

2.07

10.73

1.8

1.2

43.93

23.25

u/l

2.10

407

Nonorganic sleeping disorders, excluding more controls

360

2.26

10.70

1.1

1.2

19.81

17.23

u/l

0.15

312

Diseases of pulp and periapical tissues, including avohilmo

414

1481

1.45

10.61

1.2

26.43

24.75

u/l

0.23

347

1285

Obesity due to excess calories

185

1092

1.70

10.61

1.2

1.3

23.55

21.03

u/l

0.37

157

938

Type 2 diabetes, definitions combined

367

1461

1.48

10.60

1.2

25.92

23.01

u/l

0.51

322

1243

Unspecified haematuria

168

794

1.76

10.58

1.2

39.45

25.27

u/l

1.93

146

666

Major coronary heart disease event excluding revascularizations

254

1066

1.59

10.54

1.3

1.2

28.05

25.57

u/l

0.31

220

896

Type 2 diabetes, definitions combined, including avohilmo

370

1465

1.47

10.53

1.2

25.79

22.98

u/l

0.48

320

1249

Percutaneous Coronary Intervention

334

1367

1.50

10.50

1.2

28.32

23.83

u/l

0.99

292

1169

Conjunctivitis

306

1694

1.51

10.50

1.2

18.43

21.97

u/l

0.58

272

1455

Spondylosis

224

1129

1.62

10.40

1.2

30.35

24.69

u/l

0.71

186

964

Disorders of continuity of bone

185

2.78

10.37

1.2

1.1

20.69

22.66

u/l

0.12

160

ILD, hospital admissions

309

2.35

10.35

1.1

1.2

41.60

23.04

u/l

1.34

259

Other local infections of skin and subcutaneous tissue

180

2.80

10.31

1.4

1.1

30.90

22.81

u/l

0.44

151

Abnormal findings on diagnostic imaging of lung

205

1200

1.64

10.27

1.2

30.46

24.18

u/l

0.69

175

1024

Exclusions for E4_PCOS_BROAD

341

2.27

10.27

1.2

29.13

22.41

u/l

0.63

290

Neurological diseases, wide definition

187

2.31

10.20

1.1

1.3

16.53

21.62

u/l

0.52

164

Non-selective monoamine reuptake inhibitors

168

940

1.73

10.20

1.1

1.3

27.19

22.35

u/l

0.45

142

804

Congenital malformations, deformations and chromosomal abnormalities

224

1335

1.60

10.14

1.3

1.2

19.95

21.81

u/l

0.30

193

1155

Disorders of conjunctiva

330

1796

1.48

10.11

1.2

18.56

23.15

u/l

0.91

294

1541

Congenital malformations, deformations and chromosomal abnormalities

247

1458

1.56

10.08

1.3

1.2

20.13

22.59

u/l

0.46

212

1256

Other interstitial pulmonary diseases

313

2.31

10.06

1.1

1.2

41.60

25.21

u/l

1.09

263

Ischemic heart diseases

345

1405

1.48

10.05

1.2

26.72

24.06

u/l

0.49

302

1203

Injury of unspecified body region

129

3.13

10.02

1.3

1.2

26.64

16.25

u/l

1.29

113

Chronic ulcer of skin, not elsewhere classified

119

3.22

9.99

1.3

1.2

29.91

17.16

u/l

1.02

100

Intestinal malabsorption

3.69

9.99

1.4

1.2

33.96

16.82

u/l

1.59

Other and unspecified local infections of skin and subcutaneous tissue

167

2.84

9.94

1.4

1.1

32.00

18.90

u/l

0.96

142

Unspecified fall

205

1246

1.63

9.92

1.2

22.07

24.67

u/l

0.44

181

1062

Interstitial lung disease endpoints

315

2.30

9.92

1.1

1.2

41.60

25.30

u/l

1.08

265

Interstitial lung disease

315

2.30

9.92

1.1

1.2

41.60

25.30

u/l

1.08

265

External causes of morbidity and mortality

249

783

1.60

9.89

1.2

24.14

21.92

u/l

0.20

214

685

226

1253

1.59

9.89

1.2

1.3

32.39

25.41

u/l

0.96

192

1085

Persistent mood disorders

425

2.10

9.88

1.1

1.2

13.60

19.51

u/l

1.18

356

Macular pucker

329

2.26

9.83

1.3

30.39

23.38

u/l

0.48

279

Symptoms and signs involving the urinary system

306

1565

1.49

9.78

1.3

1.2

29.48

24.54

u/l

0.68

262

1334

Coronary revascularization (ANGIO or CABG)

330

1367

1.48

9.77

1.2

28.27

23.83

u/l

0.96

289

1169

Candidiasis

274

2.39

9.75

1.4

1.2

49.43

19.85

u/l

2.09

233

Misadventures to patients during surgical and medical care

299

2.32

9.73

1.3

1.1

49.79

20.63

u/l

2.00

258

Duodenal ulcer

181

2.72

9.64

1.2

20.44

23.44

u/l

0.27

146

Disorders of synovium and tendon

208

1133

1.61

9.59

1.3

21.21

22.99

u/l

0.24

184

973

Scar conditions and fibrosis of skin

4.05

9.52

1.2

1.1

19.19

14.50

u/l

0.20

Venous thromboembolism

227

1401

1.57

9.48

1.3

1.2

30.00

25.26

u/l

0.65

204

1189

Multiple myeloma, including Hilmo

4.14

9.45

1.4

1.1

44.36

17.77

u/l

1.55

Non-allergic asthma (mode)

363

2.16

9.44

1.2

31.71

15.31

u/l

1.63

306

Myocardial infarction, strict

186

798

1.66

9.39

1.3

1.2

28.46

26.35

u/l

0.19

157

678

Substance abuse, excluding more controls

203

1075

1.61

9.37

1.2

1.3

34.59

23.14

u/l

1.69

171

934

Other/unspecified rheumatoid arthritis

261

2.39

9.35

1.2

1.1

25.60

19.05

u/l

0.85

221

Lichen simplex chronicus and prurigo

114

3.19

9.32

1.3

1.1

14.97

19.99

u/l

0.41

Arterial embolism and thrombosis

3.36

9.30

1.2

42.67

24.29

u/l

0.51

Tubulo-interstitial nephritis, not specified as acute or chronic

104

3.29

9.30

1.3

1.2

40.71

16.90

u/l

1.08

Disorders of the thyroid gland

367

1672

1.43

9.26

1.2

27.54

24.88

u/l

0.34

314

1437

Acute upper respiratory infections

411

1805

1.40

9.24

1.3

1.2

25.22

23.99

u/l

0.18

365

1548

Intracranial trauma

218

966

1.59

9.18

1.2

29.13

25.59

u/l

0.33

187

845

ILD, hospital admissions 1, main diag only

276

2.33

9.15

1.1

1.2

44.81

24.39

u/l

1.32

232

Retention of urine

125

560

1.84

9.15

1.3

32.48

26.39

u/l

0.66

112

473

COPD (mode)

117

490

1.88

9.14

1.1

1.2

36.31

18.29

u/l

1.78

410

Degeneration of macula and posterior pole

197

971

1.62

9.13

1.3

1.2

25.60

26.76

u/l

0.11

164

834

Candidiasis

122

669

1.83

9.11

1.3

1.2

38.31

20.82

u/l

1.77

106

562

Convulsions, not elsewhere classified

387

2.10

9.08

1.2

31.54

18.97

u/l

1.05

318

Other diseases of anus and rectum

122

669

1.83

9.04

1.4

1.2

29.62

22.33

u/l

0.76

103

566

Thyrotoxicosis, other and/or unspecified

461

2.01

9.01

1.2

20.59

20.38

u/l

0.01

389

Fall involving bed

4.24

8.94

1.1

1.2

47.89

17.49

u/l

0.75

Hypothyreosis and Thyroxine purchase for inclusion criteria

361

1666

1.42

8.88

1.2

27.36

23.65

u/l

0.52

315

1427

Ischaemic heart disease, wide definition

321

1366

1.46

8.88

1.2

27.25

23.67

u/l

0.59

277

1162

Abnormal findings on diagnostic imaging of other body structures

299

2.25

8.86

1.2

33.76

20.22

u/l

0.95

253

Other symptoms and signs involving cognitive functions and awareness

189

1069

1.61

8.85

1.2

22.75

25.70

u/l

0.39

155

922

Dipeptidyl peptidase 4 (DPP-4) inhibitors

234

1220

1.54

8.78

1.2

32.61

23.76

u/l

1.51

199

1033

Urticaria and erythema

150

886

1.70

8.68

1.2

20.08

20.81

u/l

0.07

131

753

Selective serotonin reuptake inhibitors

374

1378

1.42

8.66

1.2

1.3

28.49

24.72

u/l

0.47

313

1207

Malignant neoplasm of digestive organs

142

646

1.74

8.64

1.2

42.80

22.30

u/l

2.42

122

546

Acute sinusitis

195

1138

1.59

8.62

1.3

1.2

24.80

21.74

u/l

0.36

181

975

Other specified/unspecified bacterial intestinal infections

115

3.07

8.55

1.2

37.54

16.60

u/l

1.10

Other arthrosis

201

877

1.59

8.51

1.2

1.3

27.03

26.19

u/l

0.08

180

752

Coronary atherosclerosis

266

1126

1.50

8.46

1.2

30.60

24.87

u/l

0.81

225

948

Discitis, unspecified

8.03

8.41

1.3

43.00

21.00

u/l

0.92

Benign neoplasm: Sigmoid colon

426

2.01

8.36

1.3

1.2

21.23

21.70

u/l

0.05

361

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

219

1392

1.53

8.32

1.2

17.59

21.93

u/l

0.64

195

1197

Thyrotoxicosis

116

646

1.80

8.29

1.1

1.2

22.39

21.62

u/l

0.06

549

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

178

2.59

8.26

1.3

1.2

26.02

20.01

u/l

0.66

146

Pulmonary heart disease, diseases of pulmonary circulation

134

779

1.73

8.24

1.3

1.2

35.09

25.03

u/l

1.02

119

643

Nonorganic sleeping disorders

403

2.02

8.14

1.1

1.2

19.81

18.75

u/l

0.06

349

Chronic sinusitis

173

1079

1.61

8.10

1.4

1.2

24.38

22.57

u/l

0.14

156

913

Sleep disorders (combined)

439

1692

1.36

8.09

1.2

23.88

24.53

u/l

0.10

369

1475

Other intervertebral disc disorders

304

1267

1.45

8.08

1.2

25.73

24.30

u/l

0.16

255

1095

Lung cancer and mesothelioma

297

2.11

8.06

1.2

34.33

19.79

u/l

1.23

248

Allergic conjunctivitis

226

1461

1.51

8.04

1.2

17.80

21.78

u/l

0.58

199

1262

Disorders of sclera, cornea, iris and ciliary body

211

1381

1.53

8.04

1.3

1.2

26.66

23.91

u/l

0.29

194

1170

Injuries to the ankle and foot

258

1559

1.47

8.04

1.4

1.2

26.18

22.11

u/l

0.70

226

1346

Pruritus

212

2.42

7.97

1.2

25.72

19.00

u/l

0.62

179

Disorders of skin appendages

180

1141

1.58

7.88

1.3

1.2

19.02

20.80

u/l

0.27

156

975

Procreative management

134

654

1.71

7.84

1.3

1.2

23.71

19.65

u/l

0.32

120

568

Dental caries, including avohilmo

284

995

1.46

7.75

1.2

25.25

24.61

u/l

0.07

237

863

Nerve, nerve root and plexus disorders

405

1822

1.36

7.71

1.2

21.45

25.96

u/l

1.33

357

1568

Unspecified misadventure during surgical and medical care

3.16

7.69

1.3

1.2

47.32

16.76

u/l

1.27

Hypothyroidism, other/unspecified

338

1589

1.40

7.68

1.2

27.75

24.07

u/l

0.48

293

1364

Disorders of adult personality and behaviour

107

596

1.80

7.67

1.2

22.27

19.34

u/l

0.24

513

Obesity related asthma

139

834

1.67

7.66

1.3

1.2

24.08

20.63

u/l

0.50

118

704

Major coronary heart disease event

336

1446

1.40

7.63

1.2

27.77

24.11

u/l

0.75

294

1233

Ankylosing spondylitis, ICD10

151

2.67

7.63

1.1

25.22

17.18

u/l

0.30

126

Functional dyspepsia

107

600

1.79

7.51

1.2

24.84

23.76

u/l

0.06

508

Panic disorder

256

2.24

7.48

1.2

15.00

19.34

u/l

0.42

220

Calculus of kidney and ureter

113

645

1.76

7.47

1.3

21.01

25.00

u/l

0.49

544

Retinal vascular disorders

231

2.31

7.47

1.2

29.00

27.25

u/l

0.10

199

Memory loss

171

2.53

7.41

1.2

30.82

20.52

u/l

0.61

143

Delirium, not induced by alcohol and other psychoactive substances

226

2.31

7.35

1.1

1.2

33.98

19.33

u/l

0.98

186

Other diseases of hard tissues of teeth

214

724

1.53

7.33

1.2

25.96

24.69

u/l

0.12

178

623

Dilated cardiomyopathy

221

2.32

7.30

1.1

1.2

38.95

21.68

u/l

2.50

184

Urticaria

120

702

1.71

7.28

1.2

22.10

21.41

u/l

0.05

103

601

Benign neoplasm: Transverse colon

222

2.31

7.23

1.3

1.2

40.57

20.35

u/l

0.61

189

Other embolism and thrombosis

260

2.20

7.23

1.2

28.24

19.25

u/l

0.99

216

Asthma/COPD (KELA code 203)

354

1770

1.37

7.22

1.3

1.2

31.66

23.10

u/l

1.42

305

1536

Generalized anxiety disorder

273

2.17

7.22

1.2

17.96

19.16

u/l

0.05

239

Other disorders of bone

387

1.97

7.21

1.2

1.1

28.23

20.35

u/l

0.76

334

Psoriasis vulgaris

408

1.94

7.20

1.2

25.22

23.55

u/l

0.11

342

Phobic anxiety disorders

210

2.34

7.16

1.1

1.2

27.33

20.48

u/l

0.31

183

Disorders of vitreous body

211

1369

1.49

7.14

1.3

1.2

21.02

23.24

u/l

0.35

182

1158

Dysphagia

552

1.80

7.11

1.4

1.2

28.39

22.02

u/l

0.78

461

Retinal vascular occlusion

230

2.27

7.11

1.2

27.60

26.22

u/l

0.08

198

Personality disorders

102

575

1.78

7.06

1.1

1.2

22.11

19.06

u/l

0.25

495

Open wound of head

196

1253

1.51

7.04

1.2

29.53

24.37

u/l

0.69

164

1085

Concussion

180

952

1.55

7.03

1.2

30.81

25.86

u/l

0.41

155

834

Soft tissue disorders related to use, overuse and pressure

112

650

1.73

7.02

1.2

19.00

23.77

u/l

0.74

553

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

182

2.43

7.00

1.2

19.67

19.86

u/l

0.01

153

Disorders of vitreous body and globe

215

1399

1.48

6.98

1.3

1.2

20.92

23.21

u/l

0.37

184

1185

Cerebral palsy and other paralytic syndromes

213

2.31

6.97

1.5

1.2

20.75

20.53

u/l

0.01

179

Spinal stenosis

202

1019

1.51

6.96

1.2

28.46

23.47

u/l

0.64

170

867

Inflammatory diseases of the central nervous system

147

2.60

6.94

1.2

1.1

23.09

17.17

u/l

0.47

124

Other disorders of veins

169

1086

1.55

6.90

1.2

23.55

22.06

u/l

0.23

142

916

Benign neoplasm: Rectum

394

1.94

6.87

1.2

24.16

22.28

u/l

0.12

333

Mental and behavioural disorders due to psychoactive substance use

210

1316

1.48

6.85

1.2

1.3

33.61

24.40

u/l

1.28

178

1141

Urolithiasis

119

708

1.69

6.82

1.2

1.3

20.51

24.90

u/l

0.60

601

Thiazolidinediones

228

2.25

6.82

1.2

35.11

20.55

u/l

0.86

197

Substance abuse

203

1284

1.49

6.79

1.2

1.3

34.59

24.32

u/l

1.43

171

1112

Diseases of oral cavity, salivary glands and jaws

213

730

1.50

6.73

1.2

25.14

24.64

u/l

0.04

173

629

Postmenopausal osteoporosis with pathological fracture

138

2.63

6.72

1.2

29.28

24.20

u/l

0.23

116

Superficial injury of head

504

1.81

6.70

1.2

25.93

20.61

u/l

0.72

426

Ankylosing spondylitis

162

2.48

6.67

1.1

1.2

25.23

18.89

u/l

0.22

126

Thyroiditis, ILD-related definition

199

2.32

6.64

1.2

15.27

16.99

u/l

0.25

171

Retinal detachments and breaks

141

885

1.60

6.57

1.2

23.00

23.51

u/l

0.06

116

755

Arthrosis

248

943

1.45

6.55

1.2

1.3

21.27

27.32

u/l

1.02

211

811

Hydronephrosis

182

2.37

6.52

1.3

1.2

19.70

19.21

u/l

0.03

150

Biguanides

366

1660

1.35

6.49

1.2

31.15

23.90

u/l

1.38

319

1424

Other viral diseases

101

581

1.74

6.49

1.2

29.81

18.71

u/l

1.20

502

Malignant melanoma

246

2.16

6.48

1.3

1.2

38.56

19.67

u/l

1.08

201

Malignant neoplasm of prostate

262

1.90

6.45

1.8

1.2

33.27

25.19

u/l

0.42

221

Coronary artery bypass grafting

369

1.82

6.45

1.3

37.83

29.57

u/l

0.44

313

Pacemaker

120

696

1.66

6.43

1.3

1.2

32.50

28.06

u/l

0.61

108

579

Benign neoplasm: Rectum, anus and anal canal

454

1.84

6.40

1.2

28.14

21.96

u/l

0.40

381

malignant neoplasm of male genital organs

277

1.87

6.38

1.8

1.2

35.85

24.71

u/l

0.60

230

Diabetic maculopathy

270

2.07

6.36

1.4

1.2

27.00

27.94

u/l

0.06

233

Stroke, excluding SAH

232

1179

1.44

6.33

1.3

1.2

31.68

24.78

u/l

0.87

199

1006

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

5.56

6.31

1.4

1.1

42.00

20.62

u/l

0.80

Multiple myeloma

5.56

6.31

1.4

1.1

42.00

20.62

u/l

0.80

Transport accidents

152

840

1.56

6.28

1.3

1.2

23.84

22.33

u/l

0.09

124

730

Polymyalgia rheumatica

276

2.08

6.27

1.1

1.2

23.41

22.22

u/l

0.10

234

Shoulder lesions

273

1182

1.40

6.23

1.2

22.63

25.49

u/l

0.49

232

1014

Fall on same level involving ice and snow

217

1511

1.44

6.20

1.2

28.57

22.63

u/l

0.94

192

1287

Myalgia

517

1.77

6.20

1.3

1.2

24.89

22.31

u/l

0.17

442

Zoster [herpes zoster]

197

1326

1.47

6.18

1.3

1.2

30.63

23.90

u/l

0.74

167

1123

Mental and behavioural disorders due to opioids

3.99

6.17

1.2

35.53

29.97

u/l

0.09

Unspecified acute lower respiratory infection

271

2.07

6.17

1.3

1.2

43.06

21.56

u/l

0.82

222

In situ neoplasms

154

1002

1.54

6.17

1.2

32.26

23.48

u/l

0.79

137

848

Fracture of forearm

223

1428

1.43

6.17

1.2

18.25

22.15

u/l

1.09

187

1228

Abnormalities of heart beat

132

812

1.60

6.16

1.2

1.3

25.77

21.08

u/l

0.58

116

684

Cerebrovascular diseases

283

1440

1.38

6.14

1.3

1.2

29.58

25.37

u/l

0.55

240

1231

Allergic asthma (mode), excluding more controls

394

1.87

6.12

1.3

1.2

29.09

12.96

u/l

1.42

331

Nonischemic cardiomyopathy

175

2.35

6.11

1.1

1.3

25.14

22.19

u/l

0.25

145

Fracture of skull and facial bones

425

1.84

6.10

1.2

34.75

18.83

u/l

0.76

367

Malignant melanoma, including Hilmo

327

1.97

6.08

1.2

35.49

18.80

u/l

1.13

272

Degenerative macular diseases

233

2.16

6.08

1.2

18.98

24.24

u/l

0.55

201

Polyuria

455

1.81

6.06

1.4

1.2

38.91

22.42

u/l

0.96

381

Aortic aneurysm

418

1.84

6.04

1.2

1.3

31.38

25.46

u/l

0.50

352

Coxarthrosis [arthrosis of hip](FG)

199

955

1.47

6.03

1.2

23.36

23.84

u/l

0.06

169

820

Cholecystitis

262

2.07

5.92

1.5

1.2

39.48

22.38

u/l

0.91

220

Cytomegaloviral disease

4.06

5.91

1.1

1.2

36.69

13.75

u/l

1.52

Exclusions for E4_PCOS_CONSORTIUM

278

1262

1.38

5.91

1.3

1.2

23.53

21.67

u/l

0.26

241

1084

Stomatitis and related lesions

430

1.82

5.90

1.2

38.16

21.83

u/l

1.16

370

Fissure and fistula of anal and rectal regions

503

1.75

5.89

1.1

1.2

17.87

21.94

u/l

0.57

424

Other renal tubulo-interstitial diseases

5.07

5.89

1.2

1.1

19.65

14.79

u/l

0.33

Fibroblastic disorders

518

1.74

5.89

1.3

1.2

29.18

23.70

u/l

0.46

441

Caries of enamel

324

1743

1.34

5.88

1.3

1.2

19.69

23.63

u/l

0.97

285

1506

Thyrotoxicosis with toxic multinodular goitre

124

2.60

5.88

1.2

33.96

16.97

u/l

0.59

106

Use of pramipexole

556

1.72

5.86

1.3

1.2

19.24

23.30

u/l

0.46

467

Psoriatic arthropathies

192

2.25

5.82

1.2

13.84

18.57

u/l

0.59

158

Vitamin deficiency

3.02

5.80

1.5

1.1

20.08

17.17

u/l

0.21

Vitamin deficiency, wide

3.02

5.80

1.5

1.2

20.08

17.17

u/l

0.21

Caries of dentine, including avohilmo

295

1100

1.37

5.79

1.2

25.05

24.43

u/l

0.06

243

958

Injuries to the elbow and forearm

268

1719

1.37

5.78

1.2

18.13

23.59

u/l

2.01

223

1482

Monoamine oxidase A inhibitors

265

2.05

5.77

1.2

29.83

18.96

u/l

0.48

226

Benign neoplasm: Adrenal gland

162

2.36

5.73

1.3

1.2

20.12

19.68

u/l

0.02

139

Carbimazole or st.post thyroidectomy, condition for graves disease

508

1.74

5.71

1.1

1.2

21.61

19.80

u/l

0.09

432

Pulmonary embolism

115

713

1.62

5.69

1.3

1.2

34.21

25.14

u/l

0.76

105

585

Neurological diseases

307

1139

1.36

5.59

1.2

22.15

25.26

u/l

0.45

261

1000

Malignant neoplasm of respiratory system and intrathoracic organs

319

1.86

5.58

1.1

1.2

43.70

21.86

u/l

1.40

268

Retinal detachment with retinal break

255

2.05

5.57

1.2

20.98

22.69

u/l

0.15

218

Subjective visual disturbances

101

610

1.66

5.57

1.2

18.90

23.01

u/l

0.64

513

Melanocytic naevi

112

695

1.62

5.55

1.3

1.2

22.58

20.88

u/l

0.15

592

Benign neoplasm of other and unspecified endocrine glands

283

1.99

5.53

1.3

1.2

24.07

21.09

u/l

0.19

244

Injuries to the shoulder and upper arm

311

1881

1.33

5.52

1.2

29.33

24.20

u/l

0.79

270

1617

Fenamates

229

1.93

5.52

1.1

1.2

17.19

24.66

u/l

1.46

207

Trochanteric bursitis

332

1.91

5.51

1.1

1.2

21.30

20.44

u/l

0.08

287

Ischaemic Stroke, excluding all haemorrhages

212

1112

1.42

5.50

1.2

32.68

25.59

u/l

0.81

180

948

Other and unspecified urticaria

419

1.80

5.46

1.2

24.87

21.08

u/l

0.21

359

Special screening examination for infectious and parasitic diseases

272

1.87

5.45

1.2

19.50

21.97

u/l

0.14

233

COPD, hospital admissions 3, with asthma pneumonia sepsis

508

1.67

5.44

1.1

1.2

37.26

28.03

u/l

0.59

427

Mental and behavioural disorders due to alcohol

170

1115

1.47

5.44

1.2

1.3

34.56

24.94

u/l

1.07

144

966

Pulmonary heart disease

115

722

1.60

5.43

1.3

1.2

34.21

25.13

u/l

0.76

105

591

Visual disturbances and blindness

194

1359

1.43

5.42

1.2

22.12

23.74

u/l

0.20

170

1153

Deforming dorsopathies

110

685

1.61

5.38

1.3

1.2

23.22

21.90

u/l

0.14

582

Other and unspecified vascular occlusions

173

2.27

5.38

1.1

1.3

30.06

23.01

u/l

0.44

150

Non-small cell lung cancer, including Hilmo

249

2.01

5.38

1.1

1.2

29.73

19.43

u/l

0.75

209

Dislocation, sprain and strain of joint and ligaments of hip

3.12

5.35

1.3

1.2

21.88

17.44

u/l

0.21

Basal cell carcinoma

151

692

1.51

5.33

1.3

1.2

27.09

22.24

u/l

0.61

129

582

Cystic fibrosis with pulmonary manifestations

+∞

5.29

2.6

0.0

40.40

—

u/l

—

Abscess of anal and rectal regions

137

2.42

5.28

1.2

1.1

15.96

19.00

u/l

0.22

112

Diseases of pulp and periapical tissues and dental caries

240

882

1.40

5.27

1.2

27.32

25.64

u/l

0.16

202

760

Other viral diseases

124

794

1.55

5.22

1.2

26.90

18.59

u/l

1.00

114

679

Faecal incontinence

215

2.11

5.20

1.3

1.2

24.67

19.94

u/l

0.33

180

Other disorders of skin and subcutaneous tissue, not elsewhere classified

283

1.95

5.18

1.2

26.81

21.26

u/l

0.44

238

Allergic asthma (mode)

417

1.76

5.16

1.3

1.2

29.09

14.12

u/l

1.27

352

Mental and behavioural disorders due to alcohol, excluding acute intoxication

147

982

1.49

5.16

1.2

1.3

37.69

25.05

u/l

1.30

122

842

Psychiatric diseases

359

1377

1.31

5.14

1.2

25.46

23.90

u/l

0.20

301

1197

Carcinoma in situ of skin

164

2.27

5.14

1.1

1.3

35.25

20.07

u/l

0.64

137

Basal cell carcinoma, including avohilmo

156

723

1.49

5.12

1.3

1.2

26.91

21.83

u/l

0.68

135

604

Other and unspecified injuries of head

115

2.54

5.12

1.1

1.2

16.12

16.16

u/l

0.00

100

Infection due to other mycobacteria

6.42

5.10

1.8

1.2

49.00

13.08

u/l

0.76

Other secondary coxarthrosis

3.11

5.08

1.1

1.2

40.07

18.26

u/l

1.25

Cytomegalovirus infection, IBD co-morbidity

4.51

5.07

1.1

36.69

13.38

u/l

1.54

Unstable angina pectoris

130

669

1.54

5.05

1.2

1.3

28.96

27.94

u/l

0.09

113

558

Palmar fascial fibromatosis [Dupuytren]

286

1.93

5.04

1.3

29.47

26.89

u/l

0.14

236

Malignant neoplasm of bronchus and lung, including Hilmo

333

1.79

5.00

1.2

31.06

22.00

u/l

0.83

278

Benign neoplasm: Ascending colon

301

1.90

5.00

1.2

34.19

23.46

u/l

0.53

256

Visual disturbances

179

1258

1.43

4.97

1.2

22.22

23.41

u/l

0.13

155

1068

Other pulmonary heart/vessel disease

2.88

4.93

1.3

1.2

41.00

18.31

u/l

1.65

Dermatophytosis

211

1528

1.38

4.90

1.2

25.65

23.42

u/l

0.21

186

1309

DVT of lower extremities and pulmonary embolism

159

1093

1.45

4.87

1.3

1.2

29.70

25.09

u/l

0.46

148

917

Molar incisor enamel hypoplasia

4.32

4.87

1.7

1.1

15.94

31.42

u/l

0.30

Erosion of teeth , including avohilmo

510

1.67

4.86

1.2

20.43

21.06

u/l

0.05

441

Malignant neoplasm of skin

171

812

1.45

4.86

1.3

1.2

25.52

21.06

u/l

0.64

146

681

Other malignant neoplasms of skin (=non-melanoma skin cancer)

154

717

1.48

4.85

1.3

1.2

26.77

22.04

u/l

0.60

131

600

COPD, hospital admission 2, with asthma infections

115

634

1.56

4.84

1.1

1.3

35.40

28.38

u/l

0.48

532

Coxarthrosis

177

815

1.44

4.83

1.2

1.3

22.64

25.97

u/l

0.63

149

700

Other disorders of the musculoskeletal system and connective tissue

319

1.86

4.83

1.3

1.2

22.72

21.49

u/l

0.11

273

Radiculopathy

370

1.79

4.81

1.1

1.2

21.23

22.06

u/l

0.07

299

Macular hole

113

2.50

4.79

1.3

1.2

15.74

17.64

u/l

0.18

Lumbar disc prolapse

220

1229

1.37

4.79

1.1

1.2

26.93

23.86

u/l

0.35

183

1059

Disturbances of skin sensation

101

636

1.59

4.77

1.3

1.2

21.74

21.01

u/l

0.05

540

Substance use, excluding alcohol

393

1.76

4.76

1.2

33.07

20.27

u/l

0.81

337

Gonarthrosis [arthrosis of knee](FG)

256

1104

1.35

4.75

1.2

20.25

25.60

u/l

1.21

210

951

Other disorders of lacrimal gland

141

957

1.48

4.73

1.2

21.93

22.51

u/l

0.04

117

815

Episodal and paroxysmal disorders

400

1601

1.27

4.73

1.2

25.50

24.90

u/l

0.07

336

1394

Intracranial injury

199

1358

1.39

4.73

1.2

30.50

23.11

u/l

0.84

169

1179

Other other unspecified disorders of the circulatory system

2.97

4.72

1.4

1.2

12.29

18.78

u/l

0.57

Malignant melanoma of skin, including Hilmo

251

1.96

4.71

1.3

1.2

26.95

19.14

u/l

0.72

210

Specific personality disorders

469

1.69

4.71

1.1

1.2

21.76

19.54

u/l

0.17

401

Conjunctivitis (acute, non atopic)

100

628

1.59

4.71

1.2

18.51

21.48

u/l

0.24

532

Behavioural syndromes associated with physiological disturbances and physical factors

333

1830

1.29

4.69

1.2

25.70

22.93

u/l

0.39

279

1592

Other diseases of oesophagus

158

2.22

4.68

1.4

1.1

16.85

16.38

u/l

0.05

131

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.02

4.63

1.3

1.1

23.79

25.13

u/l

0.03

Pain in thoracic spine

338

1.81

4.63

1.1

1.2

23.49

21.38

u/l

0.13

280

Secondary right heart disease

2.92

4.61

1.4

1.2

37.53

19.25

u/l

1.47

Diffuse large B-cell lymphoma

2.92

4.61

1.2

1.1

33.20

17.89

u/l

0.78

Diffuse large B-cell lymphoma, including Hilmo

2.92

4.61

1.2

1.1

33.20

17.89

u/l

0.78

Diffuse large B-cell lymphoma, helper endpoint

2.92

4.61

1.2

1.1

33.20

17.89

u/l

0.78

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

164

773

1.44

4.61

1.4

1.2

25.13

21.50

u/l

0.47

138

648

Injury, poisoning and certain other consequences of external causes

186

656

1.42

4.60

1.2

28.63

21.01

u/l

0.66

159

579

Arthropathic psoriasis

233

1.98

4.58

1.2

1.1

16.22

21.82

u/l

0.55

195

Recurrent aphthous stomatitis , including avohilmo

289

1.88

4.58

1.2

40.06

21.86

u/l

0.89

249

Diseases of the myoneural junction and muscle

240

1.97

4.58

1.2

1.1

32.68

20.27

u/l

1.32

201

Other/unspecified cytomegaloviral diseases

4.59

4.57

1.1

1.2

29.93

13.85

u/l

0.91

Multiple myeloma and malignant plasma cell neoplasms

2.63

4.57

1.4

1.2

42.38

20.18

u/l

1.16

Sequelae of injuries of lower limb

186

2.11

4.56

1.2

25.94

21.20

u/l

0.22

157

Malignant neoplasm of oral cavity, including Hilmo

2.99

4.55

1.3

1.1

51.93

19.24

u/l

0.51

Haemolytic anaemias

3.08

4.52

1.2

39.72

19.02

u/l

0.89

Acute pharyngitis

232

1.97

4.52

1.4

1.2

15.26

22.95

u/l

0.71

195

Malignant neoplasm of prostate, including Hilmo

271

1.71

4.49

1.9

1.2

30.45

24.83

u/l

0.25

226

Hernia of abdominal wall

157

1100

1.43

4.48

1.3

1.2

35.38

23.86

u/l

1.22

141

922

Emotionally unstable personality disorder

194

2.07

4.48

1.1

1.2

17.47

20.96

u/l

0.25

166

Syphilis

3.45

4.48

1.3

1.2

50.07

14.03

u/l

1.20

Syphilis

3.45

4.48

1.3

1.2

50.07

14.03

u/l

1.20

Vocal cord dysfunction

155

2.15

4.47

1.2

15.19

15.24

u/l

0.00

127

Single spontaneous delivery

691

0.61

4.47

1.2

34.36

22.34

u/l

0.47

606

Spondylopathies in diseases classified elsewhere

5.91

4.47

1.4

1.3

23.09

28.36

u/l

0.19

Anaemia in chronic diseases classified elsewhere

4.43

4.45

1.4

1.2

32.14

14.19

u/l

1.26

Gonarthrosis

218

908

1.37

4.44

1.2

1.3

21.00

27.67

u/l

1.34

180

781

Acquired haemolytic anaemia

4.10

4.42

1.2

31.87

14.97

u/l

1.53

Myocardial infarction, with ST-elevation

336

1.79

4.41

1.2

1.3

45.50

25.00

u/l

1.06

274

Keratitis

125

842

1.49

4.39

1.3

1.2

29.34

22.21

u/l

0.58

116

708

Disorders of eyelid, lacrimal system and orbit

312

1842

1.29

4.37

1.2

21.94

25.42

u/l

0.64

265

1589

Stroke, including SAH

232

1256

1.34

4.34

1.3

1.2

30.46

24.65

u/l

0.71

199

1072

Renal agenesis and other reduction defects of kidney

12.02

4.31

1.3

1.2

24.43

15.33

u/l

—

Other diseases of lip and oral mucosa

150

1053

1.43

4.27

1.2

24.23

21.44

u/l

0.25

122

900

Alcohol use disorder, ICD-based

133

913

1.46

4.26

1.2

1.3

35.12

25.49

u/l

0.94

109

781

Other disorders starting during childhood or adolescence

3.32

4.25

1.4

1.1

10.73

29.41

u/l

0.53

Malignant neoplasm of kidney, except renal pelvis

139

2.24

4.24

1.3

1.2

34.00

19.92

u/l

0.87

119

Angina pectoris

209

1025

1.36

4.24

1.2

27.04

24.76

u/l

0.23

186

869

Hyperaldosteronism

3.17

4.22

1.3

1.1

19.91

15.89

u/l

0.27

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

159

2.15

4.20

1.2

40.69

19.89

u/l

1.21

134

Early onset COPD

516

1.61

4.19

1.1

1.3

40.38

22.85

u/l

1.07

435

Maternal care for other conditions predominantly related to pregnancy

408

1.69

4.19

1.2

17.12

19.71

u/l

0.30

352

Thyrotoxicosis with diffuse goitre

313

1.80

4.17

1.1

1.2

17.62

18.08

u/l

0.04

271

Sulfonylureas

126

680

1.48

4.17

1.3

39.20

24.98

u/l

1.98

113

567

Symptoms and signs involving the nervous and musculoskeletal systems

206

1530

1.35

4.17

1.2

30.00

23.52

u/l

0.64

164

1313

Anogenital herpesviral [herpes simplex] infection

2.60

4.14

1.1

1.2

10.47

25.93

u/l

0.94

Atopic dermatitis

193

1160

1.37

4.13

1.3

1.2

24.63

20.90

u/l

0.32

171

1007

Other and unspecified mood [affective] disorders

2.54

4.13

1.1

1.2

34.04

24.67

u/l

0.18

Covid-19 suspected case

442

1.66

4.10

1.3

1.2

23.62

18.91

u/l

0.51

380

Psoriatic arthropathies, ICD10

222

1.95

4.10

1.2

1.1

13.84

21.46

u/l

1.02

187

Localized swelling, mass and lump of skin and subcutaneous tissue

117

791

1.48

4.07

1.2

29.41

21.23

u/l

0.63

105

661

Follicular cysts of skin and subcutaneous tissue

390

1.70

4.06

1.3

1.2

18.50

22.28

u/l

0.48

326

Delivery

691

0.63

4.06

1.2

33.56

22.34

u/l

0.45

606

Superficial injury of lower leg

552

1.58

4.05

1.3

1.2

30.13

22.94

u/l

0.52

470

Dental operations

223

852

1.35

4.04

1.2

27.81

25.17

u/l

0.25

186

729

Traumatic subdural haemorrhage

234

1.89

4.03

1.3

1.2

23.78

28.39

u/l

0.43

196

Viral infections characterized by skin and mucous membrane lesions

146

1031

1.42

4.02

1.2

22.67

24.01

u/l

0.13

135

867

Malignant neoplasm of urinary organs

149

2.16

4.01

1.3

1.2

32.85

20.52

u/l

0.75

125

Anogenital herpesviral [herpes simplex] infection

156

2.12

3.99

1.1

1.2

11.81

23.55

u/l

1.31

137

Hemiplegia

2.54

3.96

1.3

1.2

24.07

17.09

u/l

0.41

Other enthesopathies

107

715

1.50

3.95

1.3

1.2

35.35

22.98

u/l

0.88

611

Other infective otitis externa

106

2.37

3.90

1.2

14.75

15.80

u/l

0.08

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

547

1.57

3.90

1.2

30.91

17.06

u/l

1.00

475

Phlebitis and thrombophlebitis (not including DVT)

526

1.58

3.90

1.2

31.17

21.93

u/l

1.10

438

Ingrowing nail

2.51

3.88

1.3

1.1

20.86

14.27

u/l

0.69

Family history of malignant neoplasm

220

1.92

3.86

1.4

1.1

16.27

21.89

u/l

0.42

188

Alcohol dependence

544

1.57

3.83

1.1

1.3

39.78

24.93

u/l

1.02

460

Unspecified lump in breast

420

1.65

3.83

1.3

1.2

20.05

22.22

u/l

0.13

360

Ankylosing spondylitis, strict definition

2.85

3.79

1.1

12.41

13.33

u/l

0.11

Corneal scars and opacities

3.21

3.78

1.2

1.1

29.36

15.57

u/l

0.71

Other enthesopathy of foot (+metatarsalgia)

215

1.92

3.76

1.3

1.2

25.74

19.81

u/l

0.37

189

Thoracic aortic aneurysm

265

1.82

3.76

1.2

1.3

24.37

19.97

u/l

0.46

222

Other respiratory disorders and diseases

430

1.63

3.75

1.3

1.2

40.00

25.07

u/l

1.14

360

Other diseases of the respiratory system

430

1.63

3.75

1.3

1.2

40.00

25.07

u/l

1.14

360

Glucagon-like peptide-1 (GLP-1) analogues

105

708

1.49

3.74

1.2

1.3

25.54

20.32

u/l

0.55

601

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

105

708

1.49

3.74

1.2

1.3

25.54

20.32

u/l

0.55

601

Appendectomy

221

1613

1.31

3.74

1.3

1.2

32.71

22.13

u/l

1.40

196

1388

Sleep disorders

312

1790

1.26

3.73

1.2

24.91

23.04

u/l

0.23

260

1554

Other disorders of eye and adnexa

295

1.77

3.73

1.4

1.1

18.07

21.68

u/l

0.30

256

Superficial injury of abdomen, lower back and pelvis

273

1.80

3.73

1.3

1.2

20.12

21.81

u/l

0.13

226

COPD

157

928

1.39

3.72

1.2

33.11

24.29

u/l

0.91

132

788

Pustulosis palmaris et plantaris

2.52

3.72

1.1

18.10

21.33

u/l

0.15

Enthesopathies of lower limb, excluding foot

525

1.57

3.71

1.3

1.2

22.16

23.29

u/l

0.09

441

Hypopituitarism

109

2.30

3.68

1.3

1.1

43.30

19.83

u/l

1.07

Other headache syndromes

150

1083

1.39

3.67

1.3

1.2

21.04

22.57

u/l

0.11

127

930

Acute and subacute iridocyclitis

425

1.63

3.67

1.2

26.80

22.22

u/l

0.34

356

Otitis externa

495

1.58

3.67

1.4

1.2

30.07

22.34

u/l

0.49

418

Anterior Iridocyclitis

456

1.61

3.67

1.2

26.15

21.86

u/l

0.34

384

Metatarsalgia

196

1.95

3.67

1.3

1.2

24.10

20.37

u/l

0.20

174

Other surgical follow-up care

3.13

3.65

1.3

1.1

35.86

12.43

u/l

0.53

Injuries to the wrist and hand

348

1943

1.24

3.64

1.2

25.49

23.98

u/l

0.17

294

1687

Iridocyclitis

520

1.56

3.63

1.2

28.01

22.88

u/l

0.40

434

Other neurological diseases

257

1575

1.28

3.62

1.2

27.69

25.32

u/l

0.27

223

1341

Other psoriatic arthropathies

211

1.90

3.62

1.2

14.29

21.91

u/l

0.92

176

Symptoms and signs involving speech and voice

123

863

1.43

3.58

1.3

1.2

26.07

22.69

u/l

0.35

110

728

Malignant neoplasm of bronchus and lung

277

1.71

3.57

1.1

1.2

32.74

20.36

u/l

1.00

232

Follow-up examination after treatment for malignant neoplasms

205

1.91

3.57

1.3

1.1

27.12

25.40

u/l

0.07

171

COPD related to multimorbidity

134

804

1.41

3.55

1.1

1.3

34.49

28.77

u/l

0.43

112

677

Hallux rigidus

322

1.71

3.55

1.1

1.3

23.87

21.90

u/l

0.12

268

Other diseases of gallbladder

2.52

3.55

1.2

64.60

14.77

u/l

0.78

Viral warts

445

1.60

3.53

1.2

15.44

21.77

u/l

1.18

384

Bipolar affective disorders

368

1.66

3.53

1.2

23.94

17.56

u/l

0.46

313

Pneumonia derived septicemia

2.83

3.53

1.6

1.2

35.44

19.35

u/l

0.58

Infections with a predominantly sexual mode of transmission

635

1.50

3.52

1.2

26.87

17.99

u/l

0.72

549

Fall on and from stairs and steps

620

1.50

3.52

1.2

36.12

22.83

u/l

1.16

521

Later onset COPD, excluding more controls

299

1.66

3.52

1.2

25.91

21.24

u/l

0.47

249

Somatoform disorder

361

1.67

3.51

1.3

1.2

31.77

19.66

u/l

0.61

312

Myeloproliferative diseases

158

2.04

3.50

1.3

1.2

20.70

16.80

u/l

0.45

137

Insomnia

302

1757

1.25

3.48

1.2

25.61

23.13

u/l

0.31

249

1523

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

280

1.76

3.45

1.3

1.2

45.00

19.08

u/l

1.40

235

Superficial injury of wrist and hand

409

1.62

3.45

1.2

19.92

19.68

u/l

0.02

357

Late syphilis

4.62

3.44

1.5

1.2

50.50

14.88

u/l

—

Other follicular disorders

119

2.19

3.44

1.2

31.42

22.53

u/l

0.20

105

Sensorineural hearing loss

176

1585

0.75

3.41

1.4

1.2

23.82

26.27

u/l

0.28

157

1349

Congenital malformations of genital organs

152

2.03

3.40

1.1

1.2

13.65

20.56

u/l

0.59

133

Poisoning by drugs, medicaments and biological substances

513

1.54

3.39

1.2

30.69

19.54

u/l

0.83

439

Ptosis of eyelid

245

1.80

3.39

1.2

32.81

18.17

u/l

0.76

212

Voice disturbances

100

683

1.47

3.38

1.3

1.2

26.80

23.14

u/l

0.33

572

Complications of the puerperium, not elsewhere classified

2.85

3.36

1.5

1.1

10.80

29.48

u/l

0.66

Pustular psoriasis

2.33

3.34

1.1

1.2

18.59

17.13

u/l

0.09

Other inflammation of eyelid

306

1.71

3.32

1.4

1.2

14.44

20.57

u/l

0.97

261

Sleep apnoea

334

1753

1.23

3.32

1.2

21.37

25.25

u/l

1.04

288

1512

N06DA Anticholinesterases

698

0.61

3.31

1.1

1.2

25.22

29.03

u/l

0.28

587

Use of anticholinesterases

698

0.61

3.31

1.1

1.2

25.22

29.03

u/l

0.28

587

Other chronic obstructive pulmonary disease

149

900

1.37

3.31

1.1

1.2

34.30

24.49

u/l

0.99

125

767

Other and unspecified follicular disorders

2.63

3.30

1.2

17.40

16.98

u/l

—

Other congenital malformations

233

1.81

3.27

1.3

1.2

14.31

21.93

u/l

0.87

204

Delivery, wide proxy

551

0.63

3.27

1.3

1.2

16.18

23.41

u/l

2.03

481

Zoster [herpes zoster]

423

1.59

3.27

1.2

33.18

25.32

u/l

0.47

355

Malignant neoplasm of head and neck

122

2.14

3.25

1.3

1.2

55.95

23.11

u/l

0.56

104

Poisoning by medicine

456

1.56

3.22

1.2

32.43

19.86

u/l

0.83

392

Other diseases of upper respiratory tract

394

1694

1.21

3.20

1.3

1.2

22.50

25.42

u/l

0.47

338

1462

Other crystal arthropathies

4.21

3.20

1.1

10.30

16.67

u/l

—

D07AA Corticosteroids, weak (group I)

287

1.71

3.18

1.1

1.2

25.05

20.30

u/l

0.37

246

Other chronic obstructive pulmonary disease, including avohilmo

186

1173

1.31

3.17

1.1

1.2

32.36

25.89

u/l

0.66

157

996

Sleep apnoea, including avohilmo

353

1792

1.22

3.16

1.2

20.59

25.45

u/l

1.54

303

1550

Seborrhoeic dermatitis

165

1.95

3.13

1.6

1.1

18.04

20.09

u/l

0.10

138

Ventral hernia

572

1.49

3.13

1.3

1.2

38.14

23.59

u/l

0.89

478

Fracture at wrist and hand level

109

768

1.42

3.12

1.1

1.2

26.73

20.88

u/l

0.42

660

Melanocytic naevi of trunk

223

1.80

3.10

1.1

30.39

22.90

u/l

0.28

190

Sequelae of cerebrovascular disease

120

742

1.40

3.09

1.2

31.28

25.92

u/l

0.48

623

Sequelae of injuries, of poisoning and of other consequences of external causes

533

1.50

3.09

1.2

23.23

21.86

u/l

0.09

456

Disorders of tooth development and eruption

233

1.71

3.07

1.4

1.2

21.71

20.22

u/l

0.10

204

Fracture of foot, except ankle

510

1.51

3.06

1.5

1.2

27.81

20.51

u/l

0.64

437

Rotator cuff syndrome

204

1134

1.29

3.05

1.3

1.2

25.55

25.27

u/l

0.03

175

973

Generalized skin eruption due to drugs and medicaments

2.60

3.05

1.1

38.06

14.19

u/l

1.20

Disorders of lacrimal system

158

1189

1.33

3.01

1.2

23.06

22.47

u/l

0.05

131

1008

Diseases of salivary glands

112

801

1.40

3.00

1.3

1.2

26.22

21.98

u/l

0.36

678

Rheumatic fever with heart involvement

10.23

2.99

1.2

23.60

21.40

u/l

—

Carpal tunnel syndrome

221

1535

1.27

2.99

1.3

1.2

19.26

23.90

u/l

1.30

199

1310

Hypothyroidism, strict autoimmune, 3 medication purchases required

292

1599

1.23

2.97

1.2

25.67

23.08

u/l

0.32

257

1366

Problems related to lifestyle

155

1.94

2.94

1.1

34.55

26.28

u/l

0.21

132

Restless leg syndrome

287

1.68

2.94

1.1

1.2

13.45

20.96

u/l

1.37

247

Disorders of breast

182

1277

1.30

2.89

1.2

19.14

21.97

u/l

0.28

159

1105

Chondropathies

319

1.63

2.89

1.2

30.20

21.46

u/l

0.68

272

Adverse effects, not elsewhere classified

421

1.55

2.88

1.3

1.2

18.14

20.59

u/l

0.25

367

Colonic or urogenital fistula

657

1.43

2.88

1.1

1.2

17.50

22.66

u/l

0.85

549

Malignant neoplasm of colon

266

1.70

2.87

1.1

1.2

49.66

19.21

u/l

1.17

220

Infections with a predominantly sexual mode of transmission

115

776

1.38

2.84

1.2

31.97

17.86

u/l

0.96

677

COPD, hospital admissions

149

949

1.33

2.83

1.1

1.2

34.30

27.64

u/l

0.57

125

802

Other viral diseases, not elsewhere classified

549

1.47

2.83

1.3

1.2

28.18

18.69

u/l

0.71

471

severe traumatic brain injury, does not include concussion

455

1.52

2.83

1.2

24.51

25.47

u/l

0.07

379

Idiopathic thrombocytopenic purpura

2.79

2.82

1.3

1.1

33.38

14.69

u/l

0.88

Other blood glucose lowering drugs, excl. Insulins

376

1.57

2.82

1.2

27.25

20.98

u/l

0.37

315

COPD-related respiratory insufficiency

238

1.73

2.80

1.1

1.3

42.14

24.19

u/l

0.63

200

Crystal arthropathies, rheuma endpoint

3.61

2.79

1.1

1.0

10.30

16.00

u/l

—

Dislocation, sprain and strain of joints and ligaments of thorax

2.56

2.79

1.3

1.2

32.87

18.36

u/l

0.58

Complications of labour and delivery

148

1085

0.76

2.77

1.2

14.38

22.18

u/l

2.78

128

940

Pregnancy, childbirth and the puerperium

457

0.64

2.75

1.3

1.2

17.83

24.21

u/l

1.29

396

Other skin changes

418

1.54

2.75

1.2

25.53

24.06

u/l

0.11

350

Abnormal findings in secretions and smears from cervix uteri vagina vulva

166

963

1.30

2.73

1.2

22.06

20.32

u/l

0.11

142

844

Corneal ulcer

395

1.55

2.73

1.5

1.2

22.00

21.93

u/l

0.01

333

Malignant neoplasm of colon, including Hilmo

348

1.58

2.71

1.1

1.2

46.17

19.98

u/l

1.22

290

Aggressive periodontitis

3.03

2.70

1.2

16.83

18.18

u/l

0.06

Superficial injury of shoulder and upper arm

211

1.76

2.70

1.2

28.13

19.18

u/l

0.27

179

Other and unspecified myopathies

161

1.87

2.66

1.2

24.38

16.81

u/l

0.88

134

COPD, early/later onset

149

957

1.31

2.64

1.1

1.2

34.30

27.56

u/l

0.58

125

809

Oter anti-inflammatory and antirheumatic agents, non-steroids

283

1.48

2.56

1.2

23.24

27.16

u/l

0.23

253

Bacterial, viral and other infectious agents

156

1.87

2.56

1.1

22.64

22.97

u/l

0.01

135

Dermatographic urticaria

114

2.03

2.56

1.4

1.1

13.53

21.89

u/l

0.55

Unspecific neurodegenerative disorder

779

0.70

2.55

1.1

1.2

31.27

28.66

u/l

0.17

668

Other disorders of nervous system

128

1.96

2.55

1.5

1.2

18.35

21.78

u/l

0.28

109

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

542

1.44

2.54

1.1

1.2

13.88

20.12

u/l

1.48

471

Benign neoplasm of eye and adnexa

208

1.74

2.53

1.2

17.74

20.52

u/l

0.16

181

Suicide or other Intentional self-harm

534

1.44

2.51

1.2

33.51

20.04

u/l

0.83

456

Barrett oesophagus

2.21

2.47

1.2

16.09

15.46

u/l

0.04

Necrosis of pulp, including avohilmo

181

1430

1.26

2.46

1.2

1.3

20.44

22.28

u/l

0.28

157

1235

Other disorders of the genitourinary system

318

1.58

2.45

1.3

1.2

10.32

22.04

u/l

3.74

271

Granulomatous disorders of skin and subcutaneous tissue

2.69

2.45

1.6

1.1

25.00

15.00

u/l

0.35

Pneumonia due to Streptococcus pneumoniae

2.47

2.45

1.5

1.2

19.71

18.20

u/l

0.11

Somnolence, stupor and coma

2.25

2.44

1.3

1.2

38.75

20.46

u/l

0.52

Non-Hodgkin lymphoma, all

2.51

2.36

1.5

1.1

65.46

19.68

u/l

1.41

Diplopia

244

1.64

2.33

1.3

1.2

31.70

20.60

u/l

0.37

207

141

999

1.30

2.33

1.2

30.85

26.70

u/l

0.52

120

842

Polyarthrosis

472

1.44

2.33

1.2

27.63

23.30

u/l

0.24

402

Diseases of external ear

109

814

1.34

2.32

1.3

1.2

26.28

22.43

u/l

0.30

683

Transient ischemic attack

178

1146

1.26

2.30

1.2

28.75

24.55

u/l

0.40

151

977

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

620

1.39

2.29

1.2

30.91

19.07

u/l

0.80

534

Dermatitis due to substances taken internally

2.13

2.28

1.2

36.06

15.36

u/l

1.16

Acute and transient psychotic disorders

238

1.64

2.28

1.1

1.2

16.21

22.93

u/l

0.62

203

Umbilical hernia

555

1.41

2.24

1.2

36.46

24.26

u/l

0.98

470

Abdominal aortic aneurysm (AAA)

155

1.80

2.23

1.3

1.2

46.17

31.71

u/l

0.49

127

Other specified disorders of kidney and ureter

2.35

2.22

1.1

1.2

19.14

16.77

u/l

0.12

Migraine with aura

540

1.41

2.21

1.3

1.2

17.21

20.85

u/l

0.54

466

Periapical abscess

145

1136

1.28

2.20

1.3

1.2

19.82

23.16

u/l

0.45

124

964

Adhesive capsulitis of shoulder

400

1.48

2.20

1.1

1.2

17.56

20.72

u/l

0.41

334

Colon adenocarcinoma

195

1.70

2.18

1.1

1.2

56.04

20.02

u/l

0.92

164

Disease of hard tissues of teeth, NOS

171

709

1.26

2.15

1.2

18.74

24.05

u/l

1.25

143

611

Contusion of toe(s) without damage to nail

3.02

2.15

1.6

1.2

17.56

14.50

u/l

—

Conductive and sensorineural hearing loss

198

1638

0.81

2.15

1.3

1.2

26.71

26.18

u/l

0.04

178

1399

Bacterial, viral and other infectious agents

144

1.81

2.14

1.2

24.35

17.55

u/l

0.48

125

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

2.62

2.13

1.2

10.73

10.94

u/l

0.02

Other and unspecified disorders of vitreous body

151

1178

1.27

2.13

1.3

1.2

18.44

22.27

u/l

0.57

130

1000

Pneumococcal septicemia

2.38

2.12

1.6

1.2

25.69

18.51

u/l

0.62

Ganglion

486

1.42

2.12

1.2

16.16

22.20

u/l

1.04

417

Other neurotic disorders

2.06

2.11

1.6

1.2

14.54

16.22

u/l

0.08

Other epidermal thickening

2.22

2.11

1.4

1.2

19.27

17.69

u/l

0.09

COPD, hospital admissions 1, only main diagnosis

108

699

1.32

2.11

1.2

1.3

31.63

27.64

u/l

0.28

588

Spirochaetal infections, other/unspecified

168

1.73

2.07

1.2

1.1

18.70

20.16

u/l

0.11

146

Benign neoplasm: Small intestine

2.09

2.07

1.2

19.29

18.03

u/l

0.08

Foreign body in alimentary tract

2.03

2.06

1.3

1.1

26.83

18.92

u/l

0.39

Status post-ami

403

1.40

2.03

1.2

1.3

31.36

29.64

u/l

0.09

342

Spondylolisthesis/Spondylolysis

457

1.43

2.03

1.4

1.2

22.83

21.01

u/l

0.14

377

Maternal care for known or suspected malpresentation of fetus

248

0.52

2.02

1.4

1.2

18.22

15.98

u/l

0.07

219

Ovarian cyst

129

576

1.29

2.01

1.3

1.2

21.48

22.92

u/l

0.18

112

495

Autism spe

3.09

2.01

1.6

1.2

9.00

u/l

—

Meniscus derangement

166

897

1.25

1.99

1.2

1.3

21.30

27.67

u/l

1.17

145

770

LSIL lesion of the cervix uteri, vagina or vulva

287

1.54

1.99

1.2

24.27

18.05

u/l

0.22

251

Atrophic disorders of skin

360

1.48

1.99

1.2

17.60

22.79

u/l

0.42

303

Other congenital malformations of skin

148

1.76

1.98

1.2

1.1

15.35

20.82

u/l

0.38

130

Benign neoplasm of urinary organs

2.03

1.95

1.4

1.1

20.59

16.73

u/l

0.32

Injury of eye and orbit

249

1.57

1.94

1.2

23.13

19.92

u/l

0.25

212

Seborrhoeic keratosis

512

1.39

1.94

1.4

1.2

23.40

21.92

u/l

0.10

423

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

106

809

1.31

1.94

1.3

1.2

20.81

19.83

u/l

0.08

699

Autism

2.98

1.94

1.6

1.2

9.00

9.82

u/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

188

1218

1.22

1.93

1.2

22.99

20.71

u/l

0.17

163

1053

Plantar fascial fibromatosis

218

1.61

1.93

1.2

23.14

16.18

u/l

0.42

192

Attention to artificial openings

2.25

1.91

1.6

1.2

33.62

17.08

u/l

0.91

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

323

1.49

1.90

1.2

25.58

21.22

u/l

0.18

278

Occupational exposure to risk-factors

0.00

1.87

0.0

1.2

—

19.36

—

Dental pulpitis, including avohilmo

288

1594

1.17

1.85

1.2

1.3

18.26

23.08

u/l

1.26

237

1392

False labour

429

0.68

1.83

1.2

8.00

19.89

u/l

6.18

378

Other hammer toe(s) (acquired)

392

1.41

1.82

1.1

1.2

29.27

22.14

u/l

0.62

328

Other extrapyramidal and movement disorders in other diseases

571

1.35

1.80

1.2

15.67

22.58

u/l

1.49

477

Other abnormal immunological findings in serum

2.78

1.79

1.1

15.38

11.63

u/l

—

Dementia

812

0.76

1.79

1.2

36.62

28.10

u/l

0.51

692

Actinic keratosis

126

925

1.26

1.79

1.2

32.72

27.31

u/l

0.64

106

778

Benign neoplasm: Duodenum

2.36

1.78

1.3

1.1

23.64

16.50

u/l

0.41

Use of donepezil

431

0.62

1.77

1.1

1.2

27.74

29.72

u/l

0.08

358

Striking against or struck by other objects

676

1.32

1.76

1.3

25.30

21.48

u/l

0.28

583

Excessive attrition of teeth

167

1372

1.22

1.74

1.3

24.03

21.67

u/l

0.23

144

1177

Skin changes due to chronic exposure to nonionizing radiation

129

950

1.25

1.73

1.2

32.51

27.06

u/l

0.67

109

801

Wide developmental disorders

2.50

1.73

1.6

1.1

8.56

12.74

u/l

—

Nummular dermatitis

140

1.72

1.71

1.7

1.2

33.94

19.78

u/l

0.48

117

Graves disease, strict definition

210

1.58

1.70

1.2

1.1

13.26

21.15

u/l

0.75

183

Carcinoma in situ of breast, intraductal

226

1.55

1.70

1.3

1.2

10.67

20.32

u/l

1.89

196

Mouth breathing

121

962

1.26

1.69

1.2

1.3

26.50

22.64

u/l

0.30

108

820

Haemorrhoids and perianal venous thrombosis

715

1.30

1.68

1.2

24.99

22.42

u/l

0.23

606

Cervicalgia

484

1.37

1.67

1.3

1.2

18.71

22.68

u/l

0.46

400

Other and unspecified effects of external causes

605

1.32

1.66

1.3

1.2

17.85

19.78

u/l

0.23

517

Atopic dermatitis, strict definition with reimbursement

592

1.32

1.66

1.2

24.17

18.18

u/l

0.26

513

Other and unspecified rosacea

180

1.62

1.66

1.2

11.13

19.31

u/l

1.51

155

Unspecified event, undetermined intent

2.59

1.66

1.0

1.3

10.25

13.46

u/l

—

Foreign body entering into or through eye or natural orifice

134

1.72

1.66

1.8

1.1

19.56

19.72

u/l

0.01

113

Benign neoplasm: Kidney

2.11

1.65

1.3

1.1

15.85

16.09

u/l

0.02

Melanoma in situ of trunk

2.82

1.65

1.0

1.2

63.43

22.80

u/l

—

Dementia, including avohilmo

869

0.78

1.63

1.2

33.28

27.92

u/l

0.32

744

Colorectal cancer

434

1.38

1.63

1.1

1.2

39.74

22.16

u/l

0.83

365

642

1.29

1.62

1.3

1.2

28.78

27.22

u/l

0.09

548

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

353

1.42

1.59

1.1

1.2

13.66

18.45

u/l

0.73

307

Artrosis, including avohilmo

273

1285

1.16

1.59

1.2

22.45

27.67

u/l

0.92

228

1118

Oxicams

308

1.35

1.58

1.1

1.2

24.12

27.69

u/l

0.19

277

Emotional disorders and disorders of social functioning with onset specific to childhood

2.21

1.57

1.4

1.2

10.00

31.44

u/l

0.72

Other and unspecified nerve root and plexus disorders, also in other diseases

472

0.66

1.57

1.2

15.00

21.87

u/l

0.94

397

Contact with sharp glass

2.21

1.57

1.2

17.36

13.02

u/l

0.33

Acute suppurative otitis media

417

1.37

1.56

1.4

1.2

28.95

17.59

u/l

0.43

362

Other inflammation of vagina/vulva

2.28

1.55

1.2

1.1

35.80

16.32

u/l

—

Benign neoplasm of breast

297

1.45

1.55

1.2

17.58

21.52

u/l

0.44

252

Impetigo

2.04

1.54

1.5

1.1

40.00

13.83

u/l

0.87

Migraine with aura and triptan purchases

314

1.44

1.54

1.3

1.2

18.05

20.46

u/l

0.21

278

Unspecified mental disorder

122

987

1.24

1.51

1.1

1.3

17.29

21.12

u/l

0.53

106

843

Cerebral cysts

1.83

1.51

1.3

1.1

38.76

17.76

u/l

0.75

Acute epiglottitis

2.88

1.51

1.2

48.17

9.88

u/l

—

Other problems related to primary support group, including family circumstances

173

1.58

1.48

1.1

1.2

19.14

20.99

u/l

0.10

150

Open wound of wrist and hand

121

961

1.23

1.45

1.2

1.3

36.26

22.24

u/l

0.90

833

LSIL lesion of the cervix uteri

203

1.53

1.45

1.1

1.2

12.04

20.95

u/l

1.04

179

Burn and corrosion of wrist and hand

2.12

1.44

1.1

9.91

14.22

u/l

0.96

Maternal care related to the fetus and amniotic cavity and possible delivery problems

730

0.79

1.44

1.3

1.2

20.11

19.95

u/l

0.01

643

Toxic effect of ethanol

2.12

1.44

1.0

1.2

87.20

13.29

u/l

—

Early syphilis

3.15

1.44

1.0

1.2

49.20

15.82

u/l

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

313

1.34

1.44

1.3

1.2

22.33

16.82

u/l

0.19

279

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

2.74

1.43

1.3

1.1

44.17

19.88

u/l

—

Other disorders of breast

311

1.42

1.3

1.2

25.61

22.38

u/l

0.08

271

Other and unspecified nonorganic psychotic disorders

371

1.38

1.40

1.1

1.2

10.64

20.30

u/l

2.32

325

Superficial injury of ankle and foot

221

1.50

1.40

1.4

1.2

20.29

21.69

u/l

0.07

191

Acute nephritic syndrome

2.26

1.40

1.2

1.1

31.89

16.15

u/l

—

Car occupant injured in other and unspecified transport accidents

372

1.37

1.39

1.2

33.90

20.61

u/l

0.37

325

Single delivery by caesarean section

272

0.67

1.38

1.2

1.3

10.41

19.91

u/l

2.77

245

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

2.62

1.37

1.0

1.1

76.50

20.28

u/l

—

Internal derangement of knee

772

1.25

1.37

1.2

1.3

21.35

25.53

u/l

0.57

658

Coxibs

348

1.29

1.37

1.1

1.2

16.87

25.34

u/l

1.84

317

Epilepsy

721

1.26

1.35

1.2

28.79

23.29

u/l

0.29

615

Strabismus

581

1.29

1.34

1.3

1.2

28.50

21.66

u/l

0.45

496

Suppurative otitis media, unspecified

0.00

1.34

0.0

1.2

—

14.40

—

Missing teeth due to accident, extraction or parodontitis

197

1594

1.17

1.32

1.2

29.13

23.96

u/l

0.56

165

1357

Other bursopathies

285

1.41

1.27

1.4

1.2

20.66

21.74

u/l

0.07

241

Hyperplasia of prostate

416

1.26

1.3

41.25

29.40

u/l

0.68

355

Excessive, frequent and irregular menstruation

129

584

1.21

1.26

1.2

19.47

22.84

u/l

0.41

112

500

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

156

1284

1.18

1.25

1.2

21.16

24.94

u/l

0.47

137

1097

Hallux valgus (acquired)

105

614

1.23

1.25

1.2

16.07

22.31

u/l

1.37

526

Other and unspecified nail disorders

2.23

1.24

1.5

1.1

42.88

15.10

u/l

—

Early syphilis

2.65

1.22

1.0

1.2

49.20

14.57

u/l

—

Deficiency of other B group vitamins

2.12

1.18

1.3

1.2

13.75

20.34

u/l

—

Medical abortion

217

1023

1.15

1.18

1.2

28.02

21.27

u/l

0.68

189

878

Focal brain injury

109

1.65

1.18

1.1

1.3

21.77

18.36

u/l

0.14

Cervical disc disorders

107

882

1.21

1.18

1.2

1.3

20.05

23.46

u/l

0.29

743

Other fall from one level to another

436

1.31

1.17

1.5

1.2

17.92

22.84

u/l

0.75

371

Other and unspecified tonsillitis

499

1.26

1.17

1.1

1.2

28.99

21.63

u/l

0.45

430

Other abnormal products of conception

483

0.77

1.16

1.3

1.2

10.86

18.70

u/l

2.83

425

Persons encountering health services in other circumstances

104

852

1.22

1.16

1.3

1.2

30.58

21.41

u/l

1.12

716

Other and unspecified hydrocephalus

0.00

1.16

0.0

1.2

—

16.30

—

Suggestive for eosinophilic asthma

182

1.49

1.15

1.1

16.35

17.70

u/l

0.10

151

Use of rivastigmine

308

0.65

1.15

1.1

1.2

18.40

30.45

u/l

0.79

252

Inflammatory diseases of female pelvic organs

203

1299

1.15

1.14

1.3

1.2

20.65

21.38

u/l

0.06

175

1130

Use of antiglaucoma preparations and miotics

158

1.52

1.14

1.2

20.95

19.40

u/l

0.16

129

General examination and investigation of persons without complaint and reported diagnosis

155

687

1.18

1.14

1.2

30.67

24.17

u/l

0.45

136

589

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

1.85

1.13

1.3

1.2

74.75

13.76

u/l

0.78

Migraine

147

1014

1.18

1.13

1.3

18.79

20.48

u/l

0.25

126

878

Benign neoplasm: Other and unspecified parts of small intestine

2.35

1.12

1.0

1.2

10.57

24.83

u/l

—

Other obstetric conditions, not elsewhere classified

328

1.28

1.11

1.3

1.2

21.88

17.17

u/l

0.16

292

Injury of muscle and tendon at hip and thigh level

176

1.48

1.10

1.1

1.2

19.86

22.41

u/l

0.13

150

Use of memantine

522

0.76

1.09

1.1

1.2

37.25

29.91

u/l

0.36

441

Use of other anti-dementia drugs

522

0.76

1.09

1.1

1.2

37.25

29.91

u/l

0.36

441

456

1.28

1.09

1.3

1.2

24.88

28.68

u/l

0.34

383

Malignant cancer of tonsil and base of tongue

2.39

1.09

1.0

1.2

17.60

16.56

u/l

—

Dissociative [conversion] disorders

1.96

1.09

1.3

1.2

8.13

34.43

u/l

—

Kela-code for severe mental illness

104

864

1.20

1.08

1.1

1.2

17.81

21.42

u/l

0.40

737

Chronic laryngitis and laryngotracheitis

330

1.34

1.06

1.2

20.42

18.53

u/l

0.16

271

Certain zoonotic bacterial diseases

1.93

1.06

1.0

1.1

21.90

16.98

u/l

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

122

0.49

1.05

1.5

1.2

7.00

27.06

u/l

—

109

Alzheimer disease

556

0.79

1.04

1.1

1.2

34.09

29.68

u/l

0.23

473

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

642

1.23

1.03

1.3

1.2

20.32

19.72

u/l

0.06

559

Alcohol abuse, main dg, excluding more controls

263

1.37

1.03

1.1

1.3

34.73

20.43

u/l

0.72

225

Excessive earwax

128

1462

0.85

1.03

1.2

27.74

24.31

u/l

0.35

110

1250

Atopic dermatitis, strict definition

603

1.24

1.02

1.2

24.93

17.75

u/l

0.30

528

Alzheimer disease, including avohilmo

650

0.81

1.01

1.1

1.2

29.24

28.89

u/l

0.02

555

Anorexia (incl.atypical)

1.69

1.01

1.4

1.2

16.50

26.46

u/l

0.42

Fistulae involving female genital tract

2.01

1.00

1.1

1.2

6.00

12.38

u/l

—

Leiomyoma of uterus

222

1112

1.13

1.00

1.3

1.2

19.36

22.32

u/l

0.44

190

960

Wet age-related macular degeneration

366

1.30

1.00

1.3

1.2

32.63

28.00

u/l

0.17

304

Migraine without aura

422

1.28

0.99

1.1

1.2

12.24

18.81

u/l

1.57

370

Myocardial infarction, unclassifiable

408

1.27

0.98

1.3

1.2

43.43

28.74

u/l

0.71

341

Effects of foreign body entering through natural orifice

485

1.26

0.98

1.2

1.3

20.66

22.28

u/l

0.12

413

Abnormal involuntary movements

283

1.34

0.98

1.3

1.2

13.17

19.67

u/l

1.03

241

Other infestations

0.00

0.97

0.0

1.2

—

12.40

—

Hidradenitis suppurativa

1.86

0.96

1.3

1.1

45.50

13.51

u/l

—

Rosacea

241

1.37

0.96

1.2

1.1

13.96

21.54

u/l

0.94

208

Emotional disorders starting during childhood or adolescence

1.79

0.95

1.2

1.3

11.22

15.27

u/l

—

Gestational diabetes (for exclusion)

513

1.21

0.94

1.2

14.39

18.84

u/l

0.85

448

Allergic contact dermatitis due to drugs in contact with skin

1.90

0.94

1.3

1.1

24.29

17.68

u/l

—

Paracetamol or NSAID medication

146

1.35

0.92

1.2

13.74

17.88

u/l

0.65

129

Retinal breaks without detachment

365

1.29

0.92

1.3

1.2

20.93

21.13

u/l

0.01

312

Open wound of shoulder and upper arm

2.15

0.91

1.0

1.2

17.00

14.96

u/l

—

Diseases of male genital organs

126

543

1.17

0.91

1.3

35.94

27.47

u/l

0.61

106

470

Disorders of ocular muscles, binocular movement, accommodation and refraction

131

1122

1.16

0.91

1.3

1.2

22.94

21.31

u/l

0.15

116

956

Other spirochaetal diseases

800

1.19

0.90

1.2

16.17

21.98

u/l

1.39

674

Toxic effects of substances chiefly nonmedicinal as to source

193

1.40

0.90

1.1

1.2

29.68

24.15

u/l

0.12

163

Other and unspecified epidermal thickening

1.91

0.88

1.5

1.2

15.13

19.64

u/l

—

Major anomalies of jaw size

1.91

0.88

1.0

1.2

11.75

11.09

u/l

—

Other strabismus

464

1.25

0.88

1.3

1.2

18.53

21.32

u/l

0.22

400

Other disorders of pigmentation

1.65

0.88

1.2

22.31

15.09

u/l

0.53

Obstructed labour due to malposition and malpresentation of fetus

472

0.77

0.87

1.2

11.44

21.97

u/l

2.54

413

Deviated nasal septum

751

1.18

0.83

1.4

1.2

30.64

23.68

u/l

0.41

642

Lyme disease

798

1.18

0.83

1.2

15.54

22.00

u/l

1.68

673

Spirochaetal infections, other/unspecified

799

1.18

0.82

1.2

15.54

22.00

u/l

1.68

673

Suppurative and unspecified otitis media

634

1.19

0.82

1.4

1.2

24.15

18.18

u/l

0.30

548

Other spirochaetal diseases

809

1.18

0.82

1.2

16.17

22.01

u/l

1.41

682

Superficial injury of thorax

293

1.30

0.81

1.2

29.74

24.45

u/l

0.26

244

Benign mammary dysplasia

382

1.26

0.80

1.3

1.2

13.90

23.12

u/l

2.02

323

Acute appendicitis, no complications

156

1375

1.13

0.79

1.2

1.3

23.95

22.72

u/l

0.13

136

1180

Other specific arthropathies, wide

1.82

0.79

1.2

1.1

15.67

13.59

u/l

—

Female infertility, cervical, vaginal, other or unspecified origin

448

1.19

0.78

1.1

1.2

26.42

23.14

u/l

0.13

390

Lichen planus

295

1.29

0.78

1.3

1.2

29.52

21.10

u/l

0.44

248

Superficial injury of forearm

157

1.40

0.76

1.2

17.71

23.64

u/l

0.35

133

Female infertility

459

1.18

0.75

1.2

25.59

23.12

u/l

0.10

397

Psoriasis (vulgaris), strict definition

1.70

0.75

1.1

22.33

18.00

u/l

—

Iridocyclitis in diseases classified elsewhere

2.01

0.73

1.2

70.20

11.84

u/l

—

Paraplegia, diplegia of upper limbs

1.80

0.72

1.4

1.2

28.86

13.76

u/l

—

Juvenile osteochondrosis

1.80

0.72

1.4

1.2

10.86

11.85

u/l

—

Long labour

467

0.81

0.71

1.4

1.2

19.00

20.59

u/l

0.13

408

Diseases of inner ear

170

1475

1.12

0.71

1.2

21.06

24.13

u/l

0.43

145

1250

Female genital prolapse

531

0.85

0.71

1.1

1.2

14.45

23.42

u/l

2.24

450

Benign neoplasm: Conjunctiva

1.56

0.70

1.2

27.89

15.18

u/l

—

Impacted cerumen

186

1.35

0.70

1.1

1.2

14.85

17.02

u/l

0.21

160

Carcinoma in situ of breast, other/unspecified

1.86

0.68

1.4

1.1

6.80

17.24

u/l

—

Disorders of eyelid in diseases classified elsewhere

1.64

0.68

1.0

1.2

12.50

14.79

u/l

—

Malignant cancer of tonsil and base of tongue, including Hilmo

1.86

0.68

1.0

1.1

17.60

16.95

u/l

—

Irregular menses

142

998

1.12

0.68

1.2

16.40

19.83

u/l

0.78

129

859

Presence of other functional implants

174

1087

1.11

0.67

1.3

1.2

24.05

23.59

u/l

0.05

155

910

Alopecia areata

1.63

0.67

1.1

17.86

15.19

u/l

—

Alzheimer’s disease (Late onset)

436

0.81

0.66

1.1

1.2

38.66

30.88

u/l

0.30

369

Persons encountering health services in circumstances related to reproduction

169

1024

1.11

0.66

1.3

1.2

18.96

21.15

u/l

0.26

147

893

All dysplastic lesions of the cervix uteri, vagina or vulva

623

1.17

0.65

1.2

31.41

17.47

u/l

0.57

541

Additional codes for the location of defect, injury or illness

103

1.46

0.65

1.3

1.2

14.40

16.09

u/l

0.18

Any dementia

704

0.87

0.64

1.2

39.69

27.35

u/l

0.84

599

Herpesviral [herpes simplex] infections

579

1.18

0.63

1.2

25.07

20.27

u/l

0.33

496

Alcohol abuse, main dg

287

1.26

0.63

1.1

1.2

34.73

24.82

u/l

0.43

239

Tonsillectomy and adenotomy

116

911

0.89

0.63

1.3

1.2

24.20

18.21

u/l

0.36

101

802

Abrasion of teeth

103

906

1.14

0.63

1.3

1.2

19.59

20.92

u/l

0.15

775

Primary gonarthrosis, bilateral

169

1310

1.11

0.62

1.2

25.05

24.37

u/l

0.06

141

1123

Benign paroxysmal vertigo

794

1.15

0.62

1.2

21.86

23.07

u/l

0.09

670

Coxarthrosis, primary

192

1481

1.10

0.62

1.2

23.89

24.49

u/l

0.08

160

1262

Lesion of ulnar nerve

306

1.24

0.62

1.2

20.81

20.90

u/l

0.01

257

Appendicitis, broad definition

213

1765

1.09

0.62

1.2

29.27

23.41

u/l

0.65

190

1518

Glucosamine medication

132

1176

0.89

0.61

1.2

18.18

25.26

u/l

1.13

106

996

Degenerative diseases of the nervous system

638

0.86

0.60

1.2

33.53

28.83

u/l

0.24

540

Type of accident

695

0.85

0.60

1.2

42.94

21.53

u/l

1.35

587

Diseases of appendix

214

1771

1.09

0.60

1.2

29.15

23.37

u/l

0.64

191

1523

Oligomenorrhoea

1.54

0.59

1.3

1.2

21.88

17.49

u/l

—

Combinations of oral blood glucose lowering drugs

667

1.16

0.59

1.2

1.3

36.52

20.82

u/l

1.11

556

Extrapyramidal and movement disorders

112

996

1.13

0.59

1.3

1.2

20.80

24.78

u/l

0.35

843

Glaucoma

179

1404

1.10

0.58

1.2

21.99

25.38

u/l

0.65

151

1188

Cluster headache, strict

1.57

0.58

1.5

1.1

6.30

16.57

u/l

—

Other bullous disorders

1.51

0.58

1.1

19.00

14.98

u/l

—

Chronic iridocyclitis

1.46

0.58

1.1

1.2

13.69

17.34

u/l

0.39

Colorectal adenocarcinoma

363

1.21

0.57

1.1

1.2

45.69

21.89

u/l

0.80

304

Acute appendicitis

198

1698

1.09

0.57

1.2

30.79

23.23

u/l

0.83

175

1461

Primary coxarthrosis, bilateral

755

0.86

0.57

1.2

21.08

25.56

u/l

0.63

631

Other predominantly sexually transmitted diseases, not elsewhere classified

328

1.22

0.57

1.2

13.79

18.99

u/l

0.65

285

Postmenopausal atrophic vaginitis

104

507

1.13

0.56

1.2

16.67

23.11

u/l

1.05

430

Malignant neoplasm of cervix uteri, including Hilmo

1.67

0.56

1.0

1.1

31.00

16.84

u/l

—

Tooth agenesis EXCLUDE clefts and syndromes

1.67

0.56

1.2

35.50

38.60

u/l

—

Cerebral aneurysm, nonruptured

185

1.30

0.56

1.3

1.1

10.89

19.56

u/l

1.67

162

Injuries to the neck

467

1.18

0.55

1.3

1.2

23.73

21.83

u/l

0.09

400

Other noninflammatory disorders of vulva and perineum

230

1.26

0.55

1.2

31.46

19.81

u/l

0.27

195

Benign lipomatous neoplasm

762

0.87

0.54

1.1

1.2

13.64

22.56

u/l

2.85

635

Outcome of delivery

214

1.21

0.54

1.1

1.3

12.17

16.43

u/l

1.01

190

Contact with and exposure to communicable diseases

587

0.85

0.53

1.3

1.2

29.45

17.47

u/l

0.33

515

Tuberculosis of other organs, strict

1.54

0.53

1.5

1.2

36.17

18.15

u/l

—

Other disorders of ear

260

1826

0.93

0.52

1.3

1.2

22.36

25.83

u/l

0.51

225

1568

Salpingitis and oophoritis

498

1.17

0.52

1.5

1.2

27.31

19.53

u/l

0.25

422

Diseases of middle ear and mastoid

147

1094

1.10

0.52

1.3

1.2

25.99

21.34

u/l

0.35

135

930

Alzheimer’s disease, strict definition

475

0.85

0.51

1.1

1.2

32.92

29.61

u/l

0.14

405

Disorders of vestibular function (Vertigo)

145

1300

1.10

0.51

1.2

22.49

23.86

u/l

0.14

123

1098

Polyp of the female genital tract

106

544

1.12

0.50

1.2

20.18

23.57

u/l

0.27

463

Desensitization to allergens

1.39

0.50

1.3

1.2

15.78

25.16

u/l

—

Other melanin hyperpigmentation

1.47

0.50

1.3

1.2

15.83

18.91

u/l

—

Secondary polycythaemia

1.47

0.50

1.0

1.2

13.00

12.50

u/l

—

Congenital malformations of the circulatory system

262

1.22

0.49

1.5

1.1

26.64

23.06

u/l

0.19

221

Diabetes mellitus in pregnancy

410

1.14

0.48

1.3

1.2

17.15

21.43

u/l

0.52

359

Gonarthrosis,primary

289

1672

1.06

0.47

1.2

22.61

26.07

u/l

0.67

240

1444

Supplementary factors related to causes of morbidity and mortality classified elsewhere

740

0.88

0.46

1.2

43.78

21.24

u/l

1.52

625

Achilles tendinitis

227

1.23

0.46

1.3

1.2

17.71

19.19

u/l

0.11

187

Specific development disorders of speech and language

0.61

0.46

1.2

19.40

12.27

u/l

—

Schizophrenia or delusion, excluding more controls

639

1.13

0.45

1.1

1.2

12.13

20.20

u/l

2.87

553

Infective dermatitis

210

1.24

0.45

1.1

1.2

21.11

21.93

u/l

0.04

177

Nasal polyp

431

1.16

0.45

1.2

19.87

19.96

u/l

0.01

360

Labour and delivery complicated by fetal stress [distress]

274

0.84

0.44

1.3

1.2

14.93

19.86

u/l

0.47

241

Focal epilepsy

459

1.15

0.44

1.2

25.98

23.28

u/l

0.10

388

Vasomotor and allergic rhinitis

877

1.11

0.44

1.3

1.2

21.52

19.49

u/l

0.16

754

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

652

0.87

0.44

1.3

1.2

18.66

21.58

u/l

0.33

554

Diseases of the ear and mastoid process

368

1751

1.06

0.44

1.3

1.2

22.17

24.75

u/l

0.39

317

1513

Inguinal hernia, bilateral

197

0.76

0.44

2.0

1.2

30.73

23.88

u/l

0.21

162

Postmenopausal bleeding

105

506

1.11

0.43

1.2

27.62

23.15

u/l

0.26

429

Noninflammatory disorders of female genital tract

107

593

0.91

0.43

1.1

1.2

27.21

22.54

u/l

0.23

509

Chronic diseases of tonsils and adenoids

206

1395

0.93

0.43

1.3

1.2

19.88

23.05

u/l

0.33

178

1204

Use of galantamine

140

0.71

0.43

1.2

30.90

25.50

u/l

—

115

All dysplastic lesions of the cervix uteri

522

1.14

0.43

1.2

26.89

17.00

u/l

0.35

456

Other degenerative diseases of the nervous system

512

1.12

0.43

1.2

31.20

27.73

u/l

0.16

440

Cervicobrachial syndrome

527

1.14

0.42

1.1

1.2

32.31

22.91

u/l

0.44

444

Puerperal sepsis

371

0.83

0.42

1.3

1.2

17.27

21.66

u/l

0.44

320

Cluster headache, wide

1.43

0.41

1.5

1.1

6.30

15.61

u/l

—

therapeutic use

1.38

0.41

1.5

1.1

61.63

15.84

u/l

—

Cluster headache, strict, including avohilmo

1.39

0.40

1.5

1.1

6.55

16.26

u/l

4.56

Glaucoma-related operations

114

1.32

0.40

1.1

1.2

35.22

17.56

u/l

—

Congenital malformations of heart and great arteries

224

1.21

0.40

1.5

1.2

29.04

21.18

u/l

0.42

191

Lichen planus, including avohilmo

473

1.14

0.40

1.3

1.2

39.62

22.28

u/l

0.88

396

Acute alcohol intoxication

520

1.14

0.40

1.1

1.3

30.96

23.05

u/l

0.46

442

Torsion of ovary, ovarian pedicle and fallopian tube

1.47

0.40

1.0

1.1

13.40

13.07

u/l

—

Adenocarcinoma of pancreas

1.47

0.40

1.4

1.1

28.60

20.70

u/l

—

Crowding of teeth, including avohilmo

1.32

0.40

1.3

25.67

21.69

u/l

0.11

Acute alcohol intoxication, ICD10

389

1.16

0.40

1.0

1.2

36.38

22.82

u/l

0.70

329

Acetic acid derivatives and related substances

342

1.12

0.40

1.1

1.2

25.37

25.70

u/l

0.02

311

Nontoxic goitre/thyroid nodule

844

1.10

0.39

1.2

10.24

23.01

u/l

8.44

713

Drug-induced adrenocortical insufficiency

1.43

0.39

1.2

22.40

14.66

u/l

—

Propionic acid derivatives

363

0.89

0.39

1.1

1.2

28.30

24.76

u/l

0.16

331

Respiratory conditions due to other external agents

1.39

0.38

1.6

1.2

18.00

16.53

u/l

—

Viral encephalitis, not elsewhere classified/unspecified

1.39

0.38

1.2

1.3

41.20

15.42

u/l

—

Circumscribed brain atrophy

1.39

0.38

1.4

1.1

70.80

18.61

u/l

—

Keratoconus

1.39

0.38

1.2

71.60

12.18

u/l

—

Other sexually transmitted chlamydial diseases

1.27

0.36

1.1

1.3

8.89

32.25

u/l

—

Any dementia, excluding more controls

629

0.91

0.36

1.2

39.18

27.00

u/l

0.75

540

Parkinson's disease, including avohilmo

331

0.85

0.35

1.4

1.2

19.09

25.18

u/l

0.43

277

Pollen allergy

343

1.15

0.35

1.3

1.2

13.71

17.86

u/l

0.56

300

Organic, including symptomatic, mental disorders

150

996

1.07

0.34

1.2

31.76

26.80

u/l

0.41

127

842

Obstructed labour due to maternal pelvic abnormality

447

0.87

0.34

1.4

1.2

15.16

21.58

u/l

0.84

386

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

1.34

0.33

1.0

1.2

21.33

21.68

u/l

—

Polycystic ovarian syndrome, consortium definition

228

1278

1.06

0.33

1.2

20.05

21.81

u/l

0.25

208

1096

Other predominantly sexually transmitted diseases, not elsewhere classified

387

1.14

0.33

1.2

31.62

16.83

u/l

0.37

339

Inguinal or femoral hernia, bilateral

199

0.80

0.33

2.0

1.2

32.25

23.70

u/l

0.30

164

Other intracranial haemorrhages

1.28

0.32

1.7

1.1

48.83

23.16

u/l

—

Other obstetric trauma

1.33

0.32

1.3

1.2

18.82

25.33

u/l

0.19

Menorrhagia

109

559

1.08

0.32

1.2

23.61

23.46

u/l

0.01

478

Other disorders of prostate

1.35

0.31

1.6

1.1

37.43

19.43

u/l

—

Complications predominantly related to the puerperium

632

0.90

0.31

1.4

1.2

14.39

20.02

u/l

1.22

551

Mandibular retrognathia

0.73

0.31

1.0

1.1

35.86

22.80

u/l

—

Unspecified abortion

120

1.25

0.30

1.2

1.1

23.67

13.34

u/l

0.62

105

Presbycusis

312

1.14

0.30

1.1

1.2

20.33

29.53

u/l

0.97

255

Other specified/unspecified soft tissue disorders

1.31

0.30

1.3

1.2

68.27

18.97

u/l

0.64

Viral meningitis

1.27

0.30

1.3

1.2

5.14

14.51

u/l

—

Dentofacial anomalies [including malocclusion]

179

1519

0.95

0.30

1.3

1.2

23.79

21.76

u/l

0.22

155

1321

Primary open-angle glaucoma

841

0.92

0.30

1.2

25.56

26.85

u/l

0.11

709

Other noninflammatory disorders of uterus, except cervix

494

1.09

0.29

1.2

20.03

22.07

u/l

0.23

417

Disorder of external ear, unspecified

1.25

0.29

1.3

1.1

24.14

15.87

u/l

—

Migraine without aura and triptan purchases

344

1.13

0.29

1.1

1.2

12.37

20.48

u/l

1.51

301

Coxarthrosis, primary, with hip surgery

143

1260

1.06

0.28

1.2

22.96

25.17

u/l

0.30

119

1069

Hypertrophy of breast

451

1.11

0.27

1.1

1.2

13.28

22.20

u/l

1.24

389

Open bite

1.21

0.26

1.3

1.2

17.63

14.67

u/l

—

Uterine polyps

289

0.86

0.26

1.1

1.2

31.65

19.96

u/l

0.48

243

Pregnancy hypertension

112

940

1.07

0.26

1.2

14.52

20.55

u/l

1.90

103

817

Inflammatory disease of uterus

300

1.13

0.26

1.2

15.72

18.78

u/l

0.20

263

Blepharochalasis

842

0.93

0.26

1.3

1.2

21.20

22.11

u/l

0.06

715

Injury of muscle and tendon at lower leg level

291

1.13

0.26

1.7

1.2

26.96

26.02

u/l

0.04

243

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

299

0.87

0.26

1.0

1.1

16.40

21.49

u/l

0.48

253

Alzheimer’s disease (Late onset), excluding more controls

217

0.88

0.25

1.1

1.2

39.32

34.59

u/l

0.11

185

Other menopausal disorders

499

1.07

0.25

1.1

1.2

18.22

22.98

u/l

0.38

423

Endometriosis

104

571

1.07

0.24

1.2

28.42

23.08

u/l

0.25

490

Glaucoma, exfoliation

223

0.85

0.24

1.2

43.57

25.07

u/l

0.59

182

Viral infections of the central nervous system

133

1.20

0.24

1.3

1.1

15.88

22.38

u/l

0.27

116

Aneurysms, operations, SAH

381

0.89

0.24

1.2

15.22

20.14

u/l

0.99

323

Hydrocele

208

1.15

0.24

1.1

1.3

32.67

24.40

u/l

0.35

171

Hypertrophy of breast in women and men

504

1.09

0.23

1.2

13.42

21.93

u/l

1.35

435

Parkinson's disease

317

0.88

0.23

1.4

1.2

19.09

25.34

u/l

0.44

265

Parkinson's disease, strict definition

295

0.88

0.22

1.4

1.2

19.62

25.89

u/l

0.42

247

Lichen sclerosus et atrophicus

242

0.87

0.22

1.2

11.67

20.28

u/l

1.75

204

Other abnormal uterine and vaginal bleeding

495

0.93

0.22

1.2

25.81

20.43

u/l

0.37

416

Ulcer of vagina/vulva

1.19

0.21

1.2

9.60

15.95

u/l

—

Unknown and unspecified causes of morbidity

104

0.77

0.21

1.8

1.1

28.50

14.01

u/l

—

Manic episode

1.16

0.21

1.4

1.2

41.00

14.67

u/l

—

Cluster headache, wide,, including avohilmo

1.24

0.21

1.5

1.1

6.55

16.48

u/l

5.13

Scleritis and episcleritis

117

1.20

0.20

1.3

1.1

17.07

20.33

u/l

0.20

Endometriosis of ovary

430

1.09

0.20

1.3

1.2

40.64

23.37

u/l

0.42

366

Burn and corrosion of trunk

1.25

0.20

1.2

10.83

14.95

u/l

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

1.23

0.20

1.7

1.3

25.33

14.90

u/l

—

Muscle strain

1.23

0.20

1.5

1.2

8.00

20.98

u/l

—

Oral lichen planus

1.18

0.19

1.5

1.1

80.00

13.78

u/l

—

Glaucoma suspect

107

1016

1.05

0.19

1.2

19.80

22.85

u/l

0.55

849

Anti-inflammatory and antirheumatic products, non-steroids

363

1.07

0.18

1.1

1.2

26.83

24.76

u/l

0.10

331

Chondromalacia

1.13

0.18

1.0

1.2

49.33

16.04

u/l

—

Pre-eclampsia or eclampsia

540

1.07

0.18

1.3

1.2

15.62

21.00

u/l

0.93

460

Polycystic ovarian syndrome, broad definition

143

0.84

0.18

1.2

22.33

19.80

u/l

0.10

124

Pathological resorption of teeth

1.21

0.18

1.1

1.2

11.43

17.90

u/l

—

Impacted teeth

258

0.90

0.18

1.2

9.58

19.08

u/l

1.63

227

Other diseases of spinal cord

1.19

0.18

1.7

1.1

49.00

17.42

u/l

—

Supervision of high-risk pregnancy

284

1.08

0.18

1.1

1.3

25.74

16.82

u/l

0.26

254

Maltreatment syndromes

0.73

0.17

1.4

1.1

7.60

25.97

u/l

—

Other peripheral vertigo

196

1.12

0.16

1.2

1.1

18.65

19.55

u/l

0.05

167

Failed induction of labour

1.13

0.16

1.0

1.3

7.25

30.13

u/l

—

Benign neoplasm: Skin, unspecified

1.10

0.15

1.4

1.2

12.75

18.25

u/l

—

Dysplasia of cervi uteri

429

1.06

0.15

1.2

1.3

24.76

23.54

u/l

0.04

373

Schizophrenia

328

0.91

0.15

1.0

1.2

13.52

20.96

u/l

1.01

280

Injury of muscle and tendon at shoulder and upper arm level

861

0.95

0.15

1.2

1.3

35.04

23.18

u/l

0.68

717

Bicipital tendinitis

0.80

0.14

1.0

1.1

34.14

18.16

u/l

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

127

1063

1.04

0.14

1.2

14.64

20.28

u/l

1.85

118

918

Spontaneous abortion

122

855

0.96

0.14

1.2

13.51

19.77

u/l

2.50

111

737

Inguinal hernia

129

895

0.96

0.14

1.3

1.2

22.06

28.05

u/l

0.84

108

760

Postpartum haemorrhage due to anatomy

118

0.85

0.14

1.4

1.2

6.00

17.76

u/l

—

100

Other acquired deformities of musculoskeletal system and connective tissue

1.19

0.14

1.3

1.1

27.40

17.01

u/l

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

141

1.14

0.14

1.2

15.94

19.53

u/l

0.17

122

Dislocation, sprain and strain of joints and ligaments of knee

143

1362

0.97

0.13

1.2

18.81

21.93

u/l

0.55

129

1172

Pedal cyclist injured in noncollision transport accidents

228

1.10

0.13

1.2

26.00

21.15

u/l

0.20

194

Other benign neoplasms of skin

104

1001

1.04

0.13

1.3

1.2

19.57

23.47

u/l

0.59

849

Impingement syndrome of shoulder

579

1.05

0.13

1.1

1.3

25.87

21.68

u/l

0.29

503

Normotensive glaucoma

191

1.10

0.11

1.1

1.3

28.44

21.93

u/l

0.38

165

Tinnitus

631

1.05

0.11

1.3

1.2

17.93

23.47

u/l

0.69

528

Primary open-angle glaucoma, strict

688

0.96

0.11

1.2

23.89

25.84

u/l

0.18

573

Artificial joint operation, meniscal resection

270

1788

0.98

0.11

1.2

21.28

26.56

u/l

1.54

232

1540

Gonarthrosis, primary, with knee surgery

178

1382

1.03

0.11

1.2

19.83

25.06

u/l

1.36

149

1184

Benign neoplasm of meninges

231

1.08

0.10

1.5

1.2

17.95

19.74

u/l

0.13

201

Other hearing loss

725

1.04

0.10

1.1

1.2

23.33

27.75

u/l

0.38

608

Lichen ruber planus, wide definition including periferal and oral lichen planus

585

1.04

0.09

1.3

1.2

37.08

21.92

u/l

0.86

489

Other condition

291

1.07

0.09

1.2

61.58

22.13

u/l

1.34

245

Moderate visual impairment, binocular

1.04

0.09

1.2

1.1

12.60

15.05

u/l

—

Pedal cyclist injured in transport accident

488

1.05

0.09

1.4

1.2

20.31

21.43

u/l

0.09

414

Vascular dementia (subcortical)

1.05

0.08

1.0

1.2

48.83

23.45

u/l

—

Testicular dysfunction

1.03

0.08

1.2

1.1

11.67

18.15

u/l

—

Gestational [pregnancy-induced] hypertension

551

0.96

0.08

1.1

1.2

11.49

19.60

u/l

2.69

472

Serous carcinoma of ovary, including Hilmo

0.83

0.08

1.6

1.1

23.60

18.50

u/l

—

Placenta praevia

0.82

0.08

1.6

1.2

8.20

17.18

u/l

—

Benign neoplasm: Skin of ear and external auricular canal

0.78

0.08

1.8

1.2

6.00

19.04

u/l

—

Contact with nonpowered hand tool

0.77

0.08

1.0

1.2

7.60

16.47

u/l

—

Ectopic pregnancy

460

0.96

0.08

1.1

1.2

13.00

16.71

u/l

0.82

391

Allergic rhinitis

679

1.03

0.08

1.3

1.2

22.22

18.26

u/l

0.24

588

Other maternal disorders predominantly related to pregnancy

157

1005

0.98

0.08

1.2

17.51

20.67

u/l

0.68

145

865

Alzheimer’s disease (Early onset), excluding more controls

1.05

0.07

1.1

1.2

10.37

20.49

u/l

—

Other female pelvic inflammatory diseases

408

0.96

0.07

1.3

1.2

15.97

19.61

u/l

0.39

346

Normal-pressure hydrocephalus

0.86

0.07

1.0

1.2

17.29

20.37

u/l

—

Abnormal findings on diagnostic imaging of central nervous system

0.86

0.07

1.3

1.2

54.00

15.83

u/l

—

Benign neoplasm: Skin of eyelid, including canthus

364

1.04

0.06

1.2

13.10

21.00

u/l

1.87

311

Use of levodopa decarboxylase inhibitor

284

0.95

0.06

1.4

1.2

20.81

24.55

u/l

0.23

237

Other symptoms and signs involving the nervous and musculoskeletal systems

104

1061

0.98

0.05

1.3

1.2

36.87

21.12

u/l

1.01

906

Malignant neoplasm of ovary, including Hilmo

129

1.09

0.05

1.4

1.2

19.50

16.32

u/l

0.19

108

Antenatal screening

295

0.97

0.04

1.2

1.3

8.74

17.18

u/l

5.70

264

Later onset COPD

513

1.02

0.04

1.2

26.80

30.50

u/l

0.33

434

Schizophrenia, schizotypal and delusional disorders

725

1.02

0.04

1.1

1.2

13.67

20.70

u/l

1.80

623

Maternal care for known or suspected abnormality of pelvic organs

390

0.98

0.03

1.3

1.2

14.06

18.22

u/l

0.44

344

Nontoxic multinodular goitre

518

1.02

0.03

1.2

9.02

22.12

u/l

6.90

440

Triptan medication for migraine, single purchase ok

218

1463

1.01

0.03

1.2

16.73

22.40

u/l

1.72

187

1272

Migraine, single triptan purchase ok & required. ICD-code if available is included

218

1463

1.01

0.03

1.2

16.73

22.40

u/l

1.72

187

1272

Episcleritis

102

1.08

0.03

1.4

1.1

13.45

14.66

u/l

0.12

Infectious mononucleosis

118

0.93

0.02

1.0

1.2

15.36

25.74

u/l

0.44

106

Supervision of normal pregnancy

286

0.98

0.02

1.2

1.3

12.80

17.17

u/l

0.86

258

Nontraumatic intracranial haemmorrhage

440

1.02

0.02

1.3

1.2

21.18

25.33

u/l

0.35

375

Disorders of refraction and accommodation

598

0.98

0.02

1.3

1.2

15.02

20.10

u/l

0.95

514

Varicose veins

181

1377

0.99

0.02

1.3

1.2

27.50

24.09

u/l

0.37

151

1175

Pregnancy with abortive outcome

199

1031

1.01

0.02

1.2

25.92

21.20

u/l

0.38

171

886

Female infertility, associated with anovulation

1.08

0.02

1.2

1.3

11.60

21.64

u/l

—

Alzheimer disease, excluding more controls

271

1.02

0.02

1.2

32.57

30.74

u/l

0.06

229

Triptan medication for migraine, min. 3 purchases

146

1122

0.99

0.01

1.2

17.71

20.07

u/l

0.37

125

979

Pre-eclampsia or poor fetal growth

689

1.01

0.01

1.3

1.2

14.94

19.55

u/l

0.98

599

Other benign neoplasms of connective and other soft tissue

193

1.04

0.01

1.4

1.2

15.27

18.39

u/l

0.37

168

Parkinson's disease, excluding more controls

257

1.03

0.01

1.4

1.3

19.09

26.01

u/l

0.52

216

Parkinson's disease, strict definition, excluding more controls

242

1.02

0.00

1.4

1.3

19.62

26.05

u/l

0.44

204

Temporomandibular joint disorders, including avohilmo

108

1070

0.99

0.00

1.2

17.02

20.14

u/l

0.55

923

Peritonsillar abscess

414

0.99

0.00

1.2

25.19

18.82

u/l

0.30

352

Schizophrenia or delusion

728

1.00

0.00

1.1

1.2

12.13

20.68

u/l

3.25

625

Other disorders of eyelid

129

1224

1.00

0.00

1.2

23.69

24.99

u/l

0.12

111

1037

Presbyopia

132

0.98

0.00

1.1

1.2

14.00

20.04

u/l

0.55

111

Medical treatment for female infertility

366

1.00

0.00

1.4

1.2

15.91

19.94

u/l

0.33

321

Other symptoms and signs involving the digestive system and abdomen

392

0.99

0.00

1.3

1.2

24.38

20.49

u/l

0.28

333

Endometriosis ASRM stages 3,4

572

1.00

0.00

1.3

1.2

35.86

20.22

u/l

0.46

488

Excessive vomiting in pregnancy

144

0.97

0.00

1.1

1.2

17.29

23.88

u/l

0.31

128

Benign neoplasm: Cerebral meninges

214

0.98

0.00

1.2

19.50

20.22

u/l

0.04

187

Contraceptive management

106

747

0.99

0.00

1.4

1.2

19.33

21.22

u/l

0.15

650

Chronic suppurative otitis media

114

0.96

0.00

1.5

1.1

21.45

17.51

u/l

0.22

Placental disorders

0.00

0.0

1.1

—

12.75

—

Slow fetal growth and fetal malnutrition

0.00

0.0

1.0

—

11.50

—

Malignant neoplasm of ovary

0.90

0.00

1.3

1.2

25.50

17.49

u/l

—

Other congenital malformations of heart

0.00

0.0

1.1

—

7.75

—

Impacted maxillary molar

0.97

0.00

1.2

5.33

26.44

u/l

—

Congenital malformations of eye, ear, face and neck

0.94

-0.00

1.1

15.44

16.65

u/l

—

Pityriasis lichenoides chronica

0.00

-0.00

0.0

1.0

—

20.40

—

Birth asphyxia

0.00

-0.00

0.0

1.0

—

9.80

—

Subacute thyroiditis

0.95

-0.00

1.2

1.1

24.83

15.79

u/l

—

Postprocedural disorders of eye and adnexa, not elsewhere classified

0.00

-0.00

0.0

1.2

—

17.00

—

Congenital malformations of larynx

0.00

-0.00

0.0

1.0

—

19.40

—

Alzheimer’s disease (Early onset)

0.94

-0.00

1.1

1.2

10.38

24.69

u/l

—

Systemic atrophies primarily affecting the central nervous system

1.01

-0.00

1.1

1.2

13.29

17.02

u/l

—

Other facial nerve disorders

0.96

-0.00

1.0

1.1

7.80

14.82

u/l

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

-0.00

0.0

1.0

—

9.20

—

Impacted maxillary canine

0.00

-0.00

0.0

1.0

—

17.43

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

-0.00

0.0

1.0

—

8.00

—

Injury of blood vessels at forearm level

0.00

-0.00

0.0

1.2

—

21.80

—

Benign neoplasm: Other and unspecified parts of mouth

0.95

-0.00

1.5

1.2

33.33

19.05

u/l

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS